Document and Entity Information
Document and Entity Information | 12 Months Ended |
Dec. 31, 2023 shares | |
Entity Registrant Name | ALLOT LTD |
Entity Central Index Key | 0001365767 |
Document Type | 20-F |
Current Fiscal Year End Date | --12-31 |
Document Fiscal Year Focus | 2023 |
Document Fiscal Period Focus | FY |
Amendment Flag | false |
Document Registration Statement | false |
Document Annual Report | true |
Document Transition Report | false |
Document Shell Company Report | false |
Document Period End Date | Dec. 31, 2023 |
Entity File Number | 001-33129 |
Entity Incorporation State Country Code | IL |
Entity Address, Address Line One | 22 Hanagar Street |
Entity Address, Address Line Two | Neve Ne’eman Industrial Zone B |
Entity Address, City or Town | Hod-Hasharon |
Entity Address, Country | IL |
Entity Address, Postal Zip Code | 4501317 |
Title of 12(b) Security | Ordinary Shares, par value ILS 0.10 per share |
Trading Symbol | ALLT |
Name of Exchange on which Security is Registered | NASDAQ |
Entity Well-known Seasoned Issuer | No |
Entity Voluntary Filers | No |
Entity Current Reporting Status | Yes |
Entity Interactive Data Current | Yes |
Auditor Attestation Flag | true |
Entity Filer Category | Accelerated Filer |
Entity Emerging Growth Company | false |
Document Accounting Standard | U.S. GAAP |
Entity Shell Company | false |
Entity Common Stock, Shares Outstanding | 38,376,939 |
Auditor Firm ID | 1281 |
Auditor Location | Tel-Aviv, Israel |
Auditor Name | KOST FORER GABBAY & KASIERER |
Document Financial Statement Error Correction [Flag] | false |
Business Contact [Member] | |
Contact Personnel Name | Rael Kolevsohn |
Entity Address, Address Line One | 22 Hanagar Street |
Entity Address, Address Line Two | Neve Ne’eman Industrial Zone B |
Entity Address, City or Town | Hod-Hasharon |
Entity Address, Country | IL |
Entity Address, Postal Zip Code | 4501317 |
City Area Code | 972 |
Local Phone Number | (9) 762-8419 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 14,192 | $ 12,295 |
Restricted deposits | 1,728 | 1,050 |
Short-term bank deposits | 10,000 | 68,765 |
Available-for-sale marketable securities | 28,853 | 4,293 |
Trade receivables, net (net of allowance for credit losses of $ 25,253 and $ 2,908 on December 31, 2023 and 2022, respectively) | 14,828 | 44,167 |
Other receivables and prepaid expenses | 8,437 | 7,985 |
Inventories | 11,874 | 13,262 |
Total current assets | 89,912 | 151,817 |
NON-CURRENT ASSETS: | ||
Severance pay fund | 395 | 371 |
Restricted deposit | 158 | 0 |
Operating lease right-of-use assets | 3,057 | 5,387 |
Trade receivables, net | 0 | 4,934 |
Other assets | 704 | 864 |
Property and equipment, net | 11,189 | 14,236 |
Intangible assets, net | 915 | 3,511 |
Goodwill | 31,833 | 31,833 |
Total non-current assets | 48,251 | 61,136 |
Total assets | 138,163 | 212,953 |
CURRENT LIABILITIES: | ||
Trade payables | 969 | 11,661 |
Employees and payroll accruals | 12,566 | 14,149 |
Deferred revenues | 14,892 | 20,825 |
Short-term operating lease liabilities | 1,453 | 2,542 |
Other payables and accrued expenses | 9,528 | 11,424 |
Total current liabilities | 39,408 | 60,601 |
LONG-TERM LIABILITIES: | ||
Deferred revenues | 7,437 | 7,285 |
Long-term operating lease liabilities | 702 | 2,579 |
Accrued severance pay | 1,080 | 940 |
Convertible debt | 39,773 | 39,575 |
Total long-term liabilities | 48,992 | 50,379 |
SHAREHOLDERS' EQUITY: | ||
Ordinary shares of NIS 0.1 par value - Authorized: 200,000,000 shares at December 31, 2023and 2022; Issued: 39,192,939 and 38,186,043 shares at December 31, 2023 and 2022,respectively; Outstanding: 38,376,939 and 37,370,043 shares at December 31, 2023and 2022, respectively | 981 | 954 |
Additional paid-in capital | 312,128 | 303,298 |
Treasury share at cost - 816,000 shares at December 31, 2023 and 2022. | (3,998) | (3,998) |
Accumulated other comprehensive income | 483 | (1,254) |
Accumulated deficit | (259,831) | (197,027) |
Total shareholders' equity | 49,763 | 101,973 |
Total liabilities and shareholders' equity | $ 138,163 | $ 212,953 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parethetical 1) - ₪ / shares | Dec. 31, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Ordinary shares, par value | ₪ 0.1 | ₪ 0.1 |
CONSOLIDATED BALANCE SHEETS (_2
CONSOLIDATED BALANCE SHEETS (Parenthetical 2) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Allowance for credit losses | $ 25,253 | $ 2,908 |
Ordinary shares, shares authorized | 200,000,000 | 200,000,000 |
Ordinary shares, shares issued | 39,192,939 | 38,186,043 |
Ordinary shares, shares outstanding | 38,376,939 | 37,370,043 |
Treasury stock, shares | 816,000 | 816,000 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues: | |||
Total revenues | $ 93,150 | $ 122,737 | $ 145,600 |
Cost of revenues: | |||
Cost of Revenue | 40,464 | 39,831 | 44,553 |
Gross profit | 52,686 | 82,906 | 101,047 |
Operating expenses: | |||
Research and development (net of grant participations of $ 3,129, $ 825 and $ 167 for the years ended December 31, 2023, 2022 and 2021, respectively) | 39,115 | 49,800 | 47,093 |
Sales and marketing | 43,850 | 49,393 | 52,337 |
General and administrative | 34,656 | 15,982 | 15,145 |
Total operating expenses | 117,621 | 115,175 | 114,575 |
Operating loss | (64,935) | (32,269) | (13,528) |
Financial income, net | 3,215 | 2,134 | 339 |
Loss before income tax expense | (61,720) | (30,135) | (13,189) |
Income tax expense | 1,084 | 1,895 | 1,851 |
Net loss | $ (62,804) | $ (32,030) | $ (15,040) |
Net loss per share: | |||
Net loss per share, basic | $ (1.66) | $ (0.87) | $ (0.42) |
Net loss per share, diluted | $ (1.66) | $ (0.87) | $ (0.42) |
Weighted average number of shares used in per share computations of net loss: | |||
Weighted average number of shares used in per share, basic | 37,911,214 | 36,975,424 | 36,050,540 |
Weighted average number of shares used in per share, diluted | 37,911,214 | 36,975,424 | 36,050,540 |
Unrealized gain (loss) on available-for-sale marketable securities | $ 41 | $ (140) | $ (359) |
Net amount reclassified to earnings from available-for-sale marketable securities | 0 | 2 | (15) |
Total comprehensive gain (loss) from available-for-sale marketable securities | 41 | (138) | (374) |
Unrealized gain (loss) on foreign currency cash flow hedges transactions | (960) | (5,562) | 1,269 |
Net amount reclassified to earnings from hedging transactions | 2,656 | 4,175 | (770) |
Total comprehensive gain (loss) from hedge transactions | 1,696 | (1,387) | 499 |
Other comprehensive income (loss) | 1,737 | (1,525) | 125 |
Total comprehensive loss | (61,067) | (33,555) | (14,915) |
Product [Member] | |||
Revenues: | |||
Total revenues | 37,599 | 60,980 | 88,229 |
Cost of revenues: | |||
Cost of Revenue | 16,693 | 21,345 | 31,603 |
Service [Member] | |||
Revenues: | |||
Total revenues | 55,551 | 61,757 | 57,371 |
Cost of revenues: | |||
Cost of Revenue | $ 23,771 | $ 18,486 | $ 12,950 |
CONSOLIDATED STATEMENTS OF CO_2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Grants participations excluded from research and development costs | $ 3,129 | $ 825 | $ 167 |
CONSOLIDATED STATEMENTS OF CHAN
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands | Ordinary shares [Member] | Additional paid-in capital [Member] | Treasury share [Member] | Accumulated other comprehensive income (loss) [Member] | Accumulated deficit [Member] | Total |
Balance at Dec. 31, 2020 | $ 896 | $ 283,065 | $ (3,998) | $ 146 | $ (149,957) | $ 130,152 |
Balance, shares at Dec. 31, 2020 | 35,382,638 | |||||
Exercise of share options and restricted share units | $ 33 | 2,778 | 0 | 0 | 0 | 2,811 |
Exercise of share options and restricted share units, shares | 1,108,842 | |||||
Share-based compensation | $ 0 | 7,960 | 0 | 0 | 0 | 7,960 |
Other comprehensive income (loss) | 0 | 0 | 0 | 125 | 0 | 125 |
Net loss | 0 | 0 | 0 | 0 | (15,040) | (15,040) |
Balance at Dec. 31, 2021 | $ 929 | 293,803 | (3,998) | 271 | (164,997) | 126,008 |
Balance, shares at Dec. 31, 2021 | 36,491,480 | |||||
Exercise of share options and restricted share units | $ 25 | 226 | 0 | 0 | 0 | 251 |
Exercise of share options and restricted share units, shares | 878,563 | |||||
Share-based compensation | $ 0 | 9,269 | 0 | 0 | 0 | 9,269 |
Other comprehensive income (loss) | 0 | 0 | 0 | (1,525) | 0 | (1,525) |
Net loss | 0 | 0 | 0 | 0 | (32,030) | (32,030) |
Balance at Dec. 31, 2022 | $ 954 | 303,298 | (3,998) | (1,254) | (197,027) | $ 101,973 |
Balance, shares at Dec. 31, 2022 | 37,370,043 | 37,370,043 | ||||
Exercise of share options and restricted share units | $ 27 | (27) | 0 | 0 | 0 | $ 0 |
Exercise of share options and restricted share units, shares | 1,006,896 | |||||
Share-based compensation | $ 0 | 8,857 | 0 | 0 | 0 | 8,857 |
Other comprehensive income (loss) | 0 | 0 | 0 | 1,737 | 0 | 1,737 |
Net loss | 0 | 0 | 0 | 0 | (62,804) | (62,804) |
Balance at Dec. 31, 2023 | $ 981 | $ 312,128 | $ (3,998) | $ 483 | $ (259,831) | $ 49,763 |
Balance, shares at Dec. 31, 2023 | 38,376,939 | 38,376,939 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Cash flows from operating activities: | |||
Net loss | $ (62,804) | $ (32,030) | $ (15,040) |
Adjustments to reconcile net loss to net cash used in operating activities: | |||
Depreciation, amortization and impairment | 8,132 | 7,352 | 5,575 |
Share-based compensation | 8,845 | 9,165 | 8,000 |
Amortization of issuance costs of Convertible debt | 198 | 171 | 0 |
Changes in operating assets and liabilities: | |||
Increase (decrease) in severance pay, net | 116 | 92 | (58) |
Decrease in other assets, other receivables and prepaid expenses | 621 | 720 | 5,908 |
Decrease (increase) in accrued interest and amortization of premium on available-for sale marketable securities | (712) | 71 | 182 |
Decrease (increase) in operating lease right-of-use asset | 2,686 | 3,126 | (4,055) |
Increase (decrease) in operating leases liability | (3,322) | (3,131) | 3,604 |
Decrease (increase) in trade receivables | 34,273 | (11,629) | (16,787) |
Decrease (increase) in inventories | 1,388 | (2,170) | 1,494 |
Decrease in long-term deferred taxes, net | 0 | 0 | 420 |
Increase (decrease) in trade payables | (10,692) | 7,721 | 1,848 |
Increase (decrease) in employees and payroll accruals | (1,571) | (385) | 458 |
Increase (decrease) in deferred revenues | (5,781) | (9,970) | 1,640 |
Decrease in other payables and accrued expenses | (1,113) | (1,668) | (1,559) |
Net cash used in operating activities | (29,736) | (32,565) | (8,370) |
Cash flows from investing activities: | |||
Decrease (increase) in restricted deposits | (836) | 430 | (280) |
Investment in short-term bank deposits | (15,900) | (130,050) | (82,220) |
Withdrawal of short-term bank deposits | 74,665 | 122,220 | 68,725 |
Purchase of property and equipment | (2,489) | (5,642) | (7,642) |
Investment in available-for sale marketable securities | (46,742) | 0 | 0 |
Proceeds from sales and maturity of available-for sale marketable securities | 22,935 | 7,030 | 15,094 |
Acquisition | 0 | (500) | 0 |
Net cash provided by (used in) investing activities | 31,633 | (6,512) | (6,323) |
Cash flows from financing activities: | |||
Proceeds from exercise of share options | 0 | 251 | 2,811 |
Issuance of convertible debt | 0 | 39,404 | 0 |
Net cash provided by financing activities | 0 | 39,655 | 2,811 |
Increase (decrease) in cash and cash equivalents | 1,897 | 578 | (11,882) |
Cash and cash equivalents at the beginning of the year | 12,295 | 11,717 | 23,599 |
Cash and cash equivalents at the end of the year | 14,192 | 12,295 | 11,717 |
Cash paid during the year for: | |||
Taxes | 385 | 413 | 633 |
Non-cash activity: | |||
Right-of-use assets obtained in the exchange for operating lease liabilities | $ 356 | $ 196 | $ 6,746 |
GENERAL
GENERAL | 12 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
GENERAL | NOTE 1: - GENERAL a. Allot Ltd. (the "Company") was incorporated in November 1996 under the laws of the State of Israel. The Company is engaged in developing, selling and marketing of leading innovative network intelligence (“Allot Smart”) and security solutions (“Allot Secure”) for mobile and fixed service providers as well as enterprises worldwide. Our solutions are deployed globally for network and application analytics, traffic control and shaping, network-based security including mobile security, distributed denial of service (DDoS) protection, IoT security, and more. Allot Smart generates insightful intelligence that allows CSPs to analyze every packet of network, user, application and security data, CSPs can see, control and secure their networks, optimizing performance, minimizing costs and maximizing end-user QoE. Allot Secure provides security service for the mass market and SMB at home, at work and on the go for mobile, fixed and 5G converged networks. Allot Secure enables customers to detect security breaches and protect networks and network users from attacks. The Company's Ordinary Shares are listed in the NASDAQ Global Select Market under the symbol "ALLT" from its initial public offering in November 2006. Since November 2010, the Company's Ordinary Shares have been listed for trading in the Tel Aviv Stock Exchange as well. The Company holds twelve wholly-owned subsidiaries (the Company together with its subsidiaries shall collectively be referred to as "Allot"): Allot Communications, Inc. in Burlington, Massachusetts, United-States (the "U.S. subsidiary"), which was incorporated in 1997 under the laws of the State of California, Allot Communication Europe SARL, France (the "European subsidiary"), which was incorporated in 1998 under the laws of France, Allot Communications Japan K.K. in Tokyo, Japan (the "Japanese subsidiary"), which was incorporated in 2004 under the laws of Japan, Allot Communication (UK) Limited (the "UK subsidiary"), which was incorporated in 2006 under the laws of England and Wales, Allot Communications (Asia Pacific) Pte. Ltd. ("the Singaporean subsidiary"), which was incorporated in 2006 under the laws of Singapore, Allot India Private Limited. (the "Indian subsidiary”), which was incorporated in 2012 under the laws of India and commenced its activity in 2013, Allot Communications Africa (PTY) Ltd. (the "African subsidiary”), which was incorporated in 2013 under the laws of South Africa, Allot Communications Spain, S.L. Sociedad Unipersonal (the "Spanish subsidiary”), which was incorporated in 2015 under the laws of Spain, Allot Communications (Colombia) S.A.S (the "Colombian subsidiary”), which was incorporated in 2015 under the laws of Colombia and Allot MexSub (the "Mexican subsidiary"), which was incorporated in 2015 under the laws of Mexico, Allot Turkey Komunikasion Hizmeleri limited (the “Turkish subsidiary”), which was incorporated in 2018 under laws of Turkey, Allot Australia (PTY) LTD (the “Australian subsidiary”), which was incorporated in 2018 under the laws of Australia. The European, Singaporean, Indian, Colombian, U.S, Japanese, African and Turkish subsidiaries are engaged in sales and marketing, technical support services and other services of the Company's products. The UK and Australian subsidiaries are engaged in sales and marketing and other services. The Spanish and Mexican subsidiaries commenced operations in 2015 and are engaged in the sales and marketing, technical support and development activities of one of the Company's product lines. b. Acquisitions: a. On January 14, 2018 (the "Netonomy acquisition date"), the Company entered into a purchase agreement with the shareholders of Netonomy LTD ("Netonomy"), a developer of software-based cybersecurity solutions for the connected home. The total consideration for the acquisition was $ 3,765, which consisted of $ 3,180 paid in cash, holdback amount summing to $ 303 and additional contingent consideration at a fair value of $ 282 at the Netonomy acquisition date. As of December 31, 2021, the contingent consideration is estimated at a fair value of $ 834, The change in fair value of the contingent consideration was recorded to operating expenses. According to the agreement, the holdback amount (“Holdback Amount”) summing to $ 1,100 would be held to partially satisfy any claims for indemnification. Such amount shall be paid in three installments consisting 40%, 40% and 20% of the Holdback amount following the first, second and 30-months anniversaries of the Closing Date, respectively. Notwithstanding the aforementioned, a sum of $ 797 out of the Holdback amount shall be paid provided that certain employees keep working in the Company during the here mentioned periods (“the Restricted Holdback Amount”). As of December 31, 2023 the Company has no Holdback liability. In this agreement, the contingent consideration was payable over a two-and-a-half-year term, starting April 1, 2018 As of December 31, 2023, the Contingent Consideration Period ended however, part of Contingent Consideration was not settled yet. See Note 12b. b. On December 18, 2022 (the "Keepers acquisition date"), the Company entered into an Bussines combination (the "Keepers PPA") with the shareholders of Keepers Child Safety Ltd. ("Keepers") a private company which has a business of developing and marketing software to protect children from digital online threats. The total consideration for the acquisition was $ 1,152, which consisted of $ 500 paid in cash and an additional contingent consideration estimated at fair value of $ 652 at the Keepers acquisition date. As of December 31, 2023, the contingent consideration is estimated at fair value of $ 0. The contingent consideration consists of two components: (a) $ 1,000 paid against actual income. (b) All expected revenues exceeding $ 1,000 multiplied by 3.0% limited for the period of 10 years as of Valuation Date. The acquisition was accounted for using the purchase method of accounting in accordance with ASC No. 805, “Business Combinations” ("ASC No. 805"). Accordingly, the purchase price was allocated according to the estimated fair values of the assets acquired and the excess of the purchase price over the net tangible and identified intangible assets was assigned to goodwill. The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date: Fair value Technology $ 1,002 Goodwill 150 Net assets acquired $ 1,152 During 2023, the Company reassess it’s research and development projects in order to focuse it’s available resources. As a result of this assessment, management decided to stop further development of the Keepers technology and abandon the technology. As a result, the Company recorded an impairment for the year ended December 31, 2023, in the amount of $870. Since the Company abandon the technology, management estimate that as of December 31, 2023, the contingent consideration relating with the acquisition of Keppers has fair value of $0. Unaudited pro forma condensed results of operations: Pro forma results of operations related to this acquisition have not been prepared because they are not material to the Company’s consolidated Statements of Comprehensive Loss. |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
SIGNIFICANT ACCOUNTING POLICIES | NOTE 2: - SIGNIFICANT ACCOUNTING POLICIES The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). a. Use of estimates: The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. b. Financial statements in U.S. dollars: The majority operation of the Company and its subsidiaries are generated in U.S. dollars ("dollar") or linked to the dollar. The Company's management believes that the dollar is the currency of the primary economic environment in which the Company and its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the dollar. Accordingly, monetary accounts maintained in currencies other than the dollar are remeasured into U.S. dollars in accordance with Accounting Standards Codification No. 830, "Foreign Currency Matters" ("ASC No. 830"). All transactions gains and losses from the remeasurement of monetary balance sheet items are reflected in the statements of operations as financial income or expenses as appropriate. Financial gains and (losses) related to exchange rate differences in connection with revaluation of assets and liabilities in non-dollar denominated currencies for the years ended December 31, 2023, 2022, and 2021 amounted to $ 378, $ 442 and $ (454), respectively. c. Principles of consolidation: The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated upon consolidation. d. Cash and cash equivalents: The Company considers all unrestricted highly liquid investments which are readily convertible into cash, with a maturity of three months or less at the date of acquisition, to be cash equivalents. e. Restricted deposits: Restricted deposits consists of depoisits used as security for the company’s transactions with customers, hedging transactions and lease agreements. As of December 31, 2023 and 2022, restricted deposits were mainly denominated in U.S. dollars, amounted to $ 1,886 and $1,050, respectively, and bore a weighted average interest rate of 4.77% and 5.55%, respectively. f. Short-term bank deposits: Short-term bank deposits are deposits with maturities of more than three months but less than one year at the balance sheet date. The deposits are in dollars and bear interest at an annual weighted average rate of 6.58% and 4.05% on December 31, 2023 and 2022, respectively. g. Trade Receivable and Allowances: Trade receivables are recorded and carried at the original invoiced amount which was recognized as revenues less an allowance for any potential uncollectible amounts. The Company makes estimates of expected credit losses for the allowance for credit losses and allowance for unbilled receivables based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The estimated credit loss allowance is recorded as general and administrative expenses on the Company’s consolidated statements of income (loss). The following table displays a rollforward of the total allowance for credit losses for the years ended December 31, 2023, 2022, and 2021. 2023 2022 2021 Total allowance for credit losses – January 1 2,908 2,398 2,309 Current-period provision for expected credit losses 22,563 823 293 Write-offs (145 ) (64 ) (9 ) Recoveries collected (73 ) (249 ) (195 ) Total allowance for credit losses – December 31 25,253 2,908 2,398 During 2023, the Company recognized $ 22,563 increase in the credit losses provision. This increase was primarily due to management’s estimation regarding the deterioration in the economic conditions of four customers, mainly in Africa, during 2023 and their ability to repay their outstanding debt. h. Marketable securities: Marketable securities consist mainly of government bonds. The Company determines the appropriate classification of marketable securities at the time of purchase and re-evaluates such designation at each balance sheet date. In accordance with FASB ASC No. 320 “Investments- Debt and Equity Securities,” the Company classifies marketable securities as available-for-sale. Available-for-sale securities are stated at fair value, with unrealized gains and losses reported in accumulated other comprehensive income (loss), a separate component of shareholders’ equity, net of taxes. Realized gains and losses on sales of marketable securities, as determined on a specific identification basis, are included in financial income, net. The amortized cost of marketable securities is adjusted for amortization of premium and accretion of discount to maturity, both of which, together with interest, are included in financial income, net. The Company has classified all marketable securities as short-term, even though the stated maturity date may be one year or more beyond the current balance sheet date, because it is probable that the Company will sell these securities prior to maturity to meet liquidity needs or as part of risk versus reward objectives. Available-for-sale debt securities with an amortized cost basis in excess of estimated fair value are assessed to determine what amount of that difference, if any, is caused by expected credit losses. The Company periodically evaluates its available-for-sale debt securities for impairment. If the amortized cost of an individual security exceeds its fair value, the Company considers its intent to sell the security or whether it is more likely than not that it will be required to sell the security before recovery of its amortized basis. If either of these criteria are met, the Company writes down the security to its fair value and records the impairment charge in interest and other income, net in the Consolidated Statements of Operations. If neither of these criteria are met, the Company determines whether credit loss exists. Expected credit losses on available-for-sale debt securities are recognized in interest and other income (expense), net, on the Company’s consolidated statements of income (loss), and any remaining unrealized losses, net of taxes, are included in accumulated other comprehensive income (loss) in Shareholder's equity. As of December 31, 2023 and 2022, no credit loss impairment was recorded regarding the available for sale marketable securities. i. Inventories: Inventories are stated at the lower of cost or net realizable value. Inventory write-offs are provided to cover risks arising primarily from end of life products and from slow-moving items, technological obsolescence, and excess inventory. Inventory net write-offs during the years ended December 31, 2023, 2022 and 2021 amounted to $ 1,558, $ 905 and $ 4,593, respectively, and were recorded in cost of revenues. Provision for slow moving inventory as of December 31, 2023 and 2022 amounted to $ 8,895 and $ 8,862, respectively. Inventory cost is determined using the weighted average cost method. j. Property and equipment, net: Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets at the following annual rates: % Lab equipment 16 - 25 Computers and peripheral equipment 33 Office furniture 6 SECaaS equipment * 16 Leasehold improvements Over the shorter of the term of the lease or the useful life of the asset * SECaaS equipment – the equipment used for SECaaS revenues k. Goodwill: Goodwill represents the excess of the purchase price over the fair value of net assets of purchased businesses. Under Accounting Standards Codification No. 350, "Intangibles-Goodwill and Other" ("ASC No. 350"), goodwill is not amortized, but rather subject to an annual impairment test, or more often if there are indicators of impairment present. In accordance with ASC No. 350 the Company performs an annual impairment test at December 31 each year. ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If the Company elects not to use this option, or if the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company prepares a quantitative analysis to determine whether the carrying value of reporting unit exceeds its estimated fair value. If the carrying value of a reporting unit exceeds its estimated fair value, the Company recognizes an impairment of goodwill for the amount of this excess. The Company operates in one operating segment, and this segment comprises its only reporting unit. The Company has performed an annual impairment analysis as of December 31, 2023 and determined that the carrying value of the reporting unit was lower than the fair value of the reporting unit. Fair value is determined using market value. During the years 2023, 2022 and 2021, no impairment losses were recorded. l. Impairment of long-lived assets, Right-of-use assets, and intangible assets subject to amortization: Property and equipment, Right-of-use assets, and intangible assets subject to amortization are reviewed for impairment in accordance with ASC No. 360, "Accounting for the Impairment or Disposal of Long-Lived Assets," whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Intangible assets acquired in a business combination are recorded at fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives. Some of the acquired intangible assets are amortized over their estimated useful lives in proportion to the economic benefits realized. This accounting policy results in accelerated amortization of such customer relationships as compared to the straight-line method. All other intangible assets are amortized over their estimated useful lives on a straight-line basis. The Company has performed an annual impairment analysis as of December 31, 2023 and determined that there were circumstances indicating the asset’s carrying value may not be recoverable. During the year 2023, impairment losses were recorded in the amount of $ 1,614. During the years 2022 and 2021, no impairment losses were recorded. m. Revenue recognition: The Company generates revenues mainly from selling its products along with related maintenance and support services. At times, these arrangements may also include professional services, such as installation services or training. Some of the Company’s product sales are through resellers, distributors, OEMs and system integrators, all of whom are considered end-users. The Company also generates revenues from services, in which the Company provides network filtering and security services to its customers. The Company recognizes revenue under the core principle that transfer of control to the Company’s customers should be depicted in an amount reflecting the consideration the Company expects to receive. As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation. Some of the Company's contracts usually include combinations of products and services, that are capable of being distinct and accounted for as separate performance obligations. The products are distinct as the customer can derive the economic benefit of it without any professional services, updates or technical support. The Company allocates the transaction price to each performance obligation based on its relative standalone selling price out of the total consideration of the contract. For support, the Company determines the standalone selling prices based on the price at which the Company separately sells a renewal support contract on a stand-alone basis. For professional services, the Company determines the standalone selling prices based on the price at which the Company separately sells those services on a stand-alone basis. If the standalone selling price is not observable, the Company estimates the standalone selling price by taking into account available information such as geographic or regional specific factors, internal costs, profit objectives, and internally approved pricing guidelines related to the performance obligation. Product revenue is recognized at a point in time when the performance obligation is being satisfied. Maintenance and support related revenues are deferred and recognized on a straight-line basis over the term of the applicable maintenance and support agreement. Professional services are usually recognized at a point in time when the performance obligation is being satisfied. The Company elected the practical expedient to not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised goods or services to the customer will be one year or less. In certain contracts, the Company provides the customer with financing for a period exceeding the regular credit terms for customers. In such circumstances, the Company recognizes revenue based on the amount that reflects the price that would have been paid by the customer in cash on the date of receipt of the goods or services, and the balance is recognized in finance income. The Company also enters service contracts, in which the Company provides security as a service (SECaaS) solution to operators, which the Company considers as its customers. The Company's security as a service solution is offered to operators on a Revenue Share business model, where both the Company and the operator share the revenue generated from the operator's subscribers or a monthly fee per user. Most of the Company's security as a service contracts contain a single performance obligation comprised of series of distinct goods and services satisfied over time. The contracts consideration is based on usage by the operator's subscribers. As such, the Company allocates the variable consideration in those contracts to distinct service periods in which the service is provided and recognizes revenue for each distinct service period. Deferred revenue includes amounts received from customers for which revenue has not yet been recognized. Deferred revenues are classified as short and long-term based on their contractual term and recognized as (or when) the Company performs under the contract. The portion of the transaction price allocated to remaining performance obligations represents contracts that have not yet been recognized that include deferred revenue and amounts not yet received that will be recognized as revenue in future periods. As of December 31, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations that the Company expects to recognize is $ 59 million of which approximately $ 39 million is estimated to be recognized before December 31, 2024 and approximately $ 20 million is estimated to be recognized after December 31, 2024. The Company pays sales commissions to sales and marketing personnel based on their certain predetermined sales goals. The company evaluates its commission and capitalize only incremental commissions costs which are considered recoverable costs of obtaining a contract with a customer. These capitalized sales commissions costs are amortized over a period of benefit which is typically over the term of the customer contracts as initial commission rates are commensurate with the renewal commission rates. Amortization expenses related to these costs are included in sales and marketing expenses in the consolidated statements of operations. For the year ended December 31, 2023 and December 31, 2022 , the deferred commission was $1,572 and $1,863 accordingly. The amortization of deferred commission for 2023, 2022 and 2021 were $1,239, $1,296 and $1,394. The Company uses the practical expedient and does not assess the existence of a significant financing component when the difference between payment and revenue recognition is a year or less. The Company estimated variable consideration related to product returns based on its experience with historical product returns and other known factors. Such provisions amounted to $90 and $90 as of December 31, 2023 and 2022, respectively. As of December 31, 2023 and 2022, this provision was recorded as part of other payables and accrued expenses. The Company recognizes term-based license agreements at the point in time when control transfers and the associated maintenance revenues over the contract period. n. Cost of revenues: Cost of revenues consists primarily of costs of materials and the cost of maintenance and services, resulting from costs associated with support, customer success and professional services. o. Research and development costs: Accounting Standards Codification No. 985-20, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility. Based on the Company's product development process, technological feasibility is established upon the completion of a working model. The Company does not incur material costs between the completion of a working model and the point at which the products are ready for general release. Therefore, research and development costs are charged to the consolidated statement of comprehensive loss as incurred. p. Severance pay: The liability in Israel for substantially all of the Company`s employees in respect of severance pay liability is calculated in accordance with Section 14 of the Severance Pay Law -1963 (herein- "Section 14"). Section 14 states that Company's contributions for severance pay shall be in line of severance compensation and upon release of the policy to the employee, no additional obligations shall be conducted between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. Furthermore, the related obligation and amounts deposited on behalf of such obligation under Section 14, are not stated on the balance sheet, because pursuant to the current ruling, they are legally released from the obligation to employees once the deposits have been paid. There are a limited number of employees in Israel, for whom the Company is liable for severance pay. The Company's liability for severance pay for its Israeli employees was calculated pursuant to Section 14, based on the most recent monthly salary of its Israeli employees multiplied by the number of years of employment as of the balance sheet date for such employees. The Company's liability was partly provided by monthly deposits with severance pay funds and insurance policies and the remainder by an accrual. Severance expense for the years ended December 31, 2023, 2022 and 2021, amounted to $ 6,057, $ 3,516 and $ 2,456, respectively. During 2023, the Company implemented a cost reduction plan which included separation of employees which derived the 2023 severance exepenses. q. Accounting for share-based compensation: The Company accounts for share-based compensation in accordance with Accounting Standards Codification No. 718, "Compensation - Stock Compensation" ("ASC No. 718") that requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated statement of comprehensive loss. For graded vesting with only service condition the Company recognizes compensation expenses for the value of its awards based on the straight-line method over the requisite service period of each of the awards, net of estimated forfeitures. A modification to the terms of an award should be treated as an exchange of the original award for a new award with total compensation cost equal to the grant-date fair value of the original award plus the incremental value measured at the same date. Under ASC 718, the calculation of the incremental value is based on the excess of the fair value of the new (modified) award based on current circumstances over the fair value of the original award measured immediately before its terms are modified based on current circumstances. The Company estimated the forfeiture rate based on historical forfeitures of equity awards and adjusted the rate to reflect changes in facts and circumstances if any. The following table sets forth the total share-based compensation expense resulting from share options, restricted share units and Phantoms granted to employees included in the consolidated statements of comprehensive loss, for the years ended December 31, 2023, 2022 and 2021: Year ended December 31, 2023 2022 2021 Cost of revenues $ 1,219 $ 1,133 $ 581 Research and development 3,010 3,168 2,499 Sales and marketing 2,651 2,943 3,212 General and administrative 1,965 1,921 1,708 Total share-based compensation expense $ 8,845 $ 9,165 $ 8,000 During 2023, 2022 and 2021 no options were granted by the Company. The computations of expected volatility and suboptimal exercise multiple is based on the average of the Company's realized historical share price. The computation of the suboptimal exercise multiple and the forfeiture rates are based on the grantee's expected exercise prior and post vesting termination behavior. The interest rate for a period within the contractual life of the award is based on the U.S. Treasury Bills yield curve in effect at the time of grant. The Company currently has no plans to distribute dividends and intends to retain future earnings to finance the development of its business. The expected life of the share options represents the weighted-average period the share options are expected to remain outstanding and is a derived output of the binomial model. The expected life of the share options is impacted by all of the underlying assumptions used in the Company's model. The option pricing model of the of restricted share units ("RSUs") is based on the closing market value of the underlying shares at the date of grant. The expected annual pre-vesting forfeiture rate affects the number of vested RSUs. Based on the Company's historical experience, the pre-vesting is in the range of 0%-30% in the years 2023, 2022 and 2021. r. Treasury share: In the past, the Company repurchased its Ordinary shares on the open market and holds such shares as treasury share. The Company presents the cost to repurchase treasury share as a reduction of shareholders' equity. s. Concentration of credit risks: Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, short-term bank deposits, trade receivables and derivative instruments. The majority of cash and cash equivalents and short-term deposits of the Company are invested in dollar deposits in major U.S. and Israeli banks. Such investments in the United States may be in excess of insured limits and are not insured in other jurisdictions. Generally, the cash and cash equivalents and short-term bank deposits may be redeemed upon demand, and therefore, bear minimal risk. Marketable securities include investments in Dollar linked corporate and government bonds. Marketable securities consist of highly liquid debt instruments with high credit standing. The Company’s investment policy, approved by the Board of Directors, limits the amount the Group may invest in any one type of investment or issuer, thereby reducing credit risk concentrations. Management believes that the portfolio is well diversified and, accordingly, minimal credit risk exists with respect to these marketable debt securities. The Company's trade receivables are derived from sales to customers located in EMEA, as well as in APAC, Latin America and the United States. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers and establishes an allowance for credit losses on a specific basis. Allowance for credit losses amounted to $ 25,253 and $ 2,908 as of December 31, 2023 and 2022, respectively. See note 2g above. As of 31.12.2023 we have past due of $2 million. The Company utilizes foreign currency forward contracts to protect against risk of overall changes in exchange rates for some of its currencies exposure. The derivative instruments hedge a portion of the Company's non-dollar currency exposure. Counterparties to the Company’s derivative instruments are all major financial institutions and its exposure is limited to the amount of any asset resulting from the forward contracts. t. Government grants: Grants from the Israel Innovation Authority (IIA): Participation grants from the Israel Innovation Authority (Previously known as the Office of the Chief Scientist) for research and development activity are recognized at the time the Company is entitled to such grants on the basis of the costs incurred and included as a deduction of research and development costs. Research and development non royalty bearing grants recognized amounted to $ 552, $ 539 and $ (42) in 2023, 2022 and 2021, respectively. Grants from the Spain Tax Authorities: Participation grants from the Spain Tax Authorities for research and development activity are recognized at the time the Company is entitled to such grants on the basis of the costs incurred and included as a deduction of research and development costs. Research and development non royalty bearing grants recognized amounted to $ 2,577 and $ 286 in 2023 ,2022 respectively. u. Income taxes: The Company accounts for income taxes in accordance with Accounting Standards Codification No. 740, "Income Taxes" ("ASC No. 740"). ASC No. 740 prescribes the use of the liability method, whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that some portion or all of the deferred tax assets will not be realized. The deferred tax assets and liabilities are classified to non-current assets and liabilities, respectively. ASC No. 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income. v. Basic and diluted net income (loss) per share: Basic net income (loss) per share is computed based on the weighted average number of Ordinary Shares outstanding during each year. Diluted net income (loss) per share is computed based on the weighted average number of Ordinary Shares outstanding during each year, plus dilutive potential Ordinary Shares considered outstanding during the year, in accordance with FASB ASC 260 "Earnings Per Share". For the years ended December 31, 2023, 2022 and 2021, all outstanding options and RSUs have been excluded from the calculation of the diluted net loss per share since their effect was anti-dilutive. The amount of those options and RSU’s was: 2,665,194, 2,735,125, 2,613,894 respectively. w. Comprehensive loss: The Company accounts for comprehensive loss in accordance with Accounting Standards Codification No. 220, "Comprehensive Income" ("ASC No. 220"). This statement establishes standards for the reporting and display of comprehensive loss and its components in a full set of general The following table shows the components and the effects on net loss of amounts reclassified from accumulated other comprehensive loss as of December 31, 2023: Year ended December 31, 2023 Unrealized gain (losses) on marketable securities Unrealized gains (losses) on cash flow hedges Total Balance as of December 31, 2022 $ (40 ) $ (1,214 ) $ (1,254 ) Changes in other comprehensive loss before reclassifications 41 (960 ) (919 ) Amounts reclassified from accumulated other comprehensive loss to: Cost of revenues - 475 475 Research and development - 1,198 1,198 Sales and marketing - 542 542 General and administrative - 441 441 Net current-period other comprehensive loss 41 1,696 1,737 Balance as of December 31, 2023 $ 1 $ 482 $ 483 There was no income tax expense or benefit allocated to other comprehensive income, including reclassification adjustments for the year ended December 31, 2023. x. Fair value of financial instruments: The carrying amounts of short-term bank deposits, trade receivables, other receivables, trade payables and other payables approximate their fair value due to the short-term maturities of such instruments. The Company measures its cash and cash equivalents, marketable securities, derivative instruments and earn-out considerations at fair value. Fair value is an exit price, representing the amount that would be received if the Company were to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. The Company uses a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value: Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 - Include other inputs that are directly or indirectly observable in the marketplace, other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets with insufficient volume or infrequent transactions, or other inputs that are observable (model-derived valuations in which significant inputs are observable), or can be derived principally from or corroborated by observable market data; and Level 3 - Unobservable inputs which are supported by little or no market activity. The Company categorized each of its fair value measurements in one of those three levels of hier |
AVAILABLE-FOR-SALE MARKETABLE S
AVAILABLE-FOR-SALE MARKETABLE SECURITIES | 12 Months Ended |
Dec. 31, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
AVAILABLE-FOR-SALE MARKETABLE SECURITIES | NOTE 3: - AVAILABLE-FOR-SALE MARKETABLE SECURITIES The following is a summary of available-for-sale marketable securities: December 31, 2023 December 31, 2022 Amortized cost Gross unrealized gain Gross unrealized Fair value Amortized cost Gross unrealized Gross unrealized Fair value Available-for-sale - matures within one year: Governmental debentures $ 28,495 $ 9 $ - $ 28,504 $ - $ - $ - $ - Corporate debentures 357 - (8 ) 349 4,029 - (37 ) 3,992 28,852 9 (8 ) 28,853 4,029 - (37 ) 3,992 Available-for-sale - matures after one year through three years: Governmental debentures - - - - - - - - Corporate debentures - - - - 304 - (3 ) 301 - - - - 304 - (3 ) 301 $ 28,852 $ 9 $ (8 ) $ 28,853 $ 4,333 $ - $ (40 ) $ 4,293 As of December 31, 2023, the Company had no investments with a significant unrealized loss for more than 12 months. As of December 31,2023, no credit loss impairment was recorded regarding the available for sale marketable securities. |
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE MEASUREMENTS | NOTE 4: - FAIR VALUE MEASUREMENTS In accordance with ASC No. 820, the Company measures its marketable securities and foreign currency derivative instruments at fair value. Cash equivalents and available for sale marketable securities are classified within Level 1 or Level 2. This is because these assets are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. This year, the earn-out liability related to the acquisitions of Keepers are classified within Level 3 because these liabilities were based on present value calculations and an external valuation model whose inputs include market interest rates, estimated operational capitalization rates and volatilities. The fair value of the consideration was determined according to discounted cash flow. The Company's financial net assets measured at fair value on a recurring basis, including accrued interest components, consisted of the following types of instruments as of December 31, 2023 and 2022, respectively: As of December 31, 2023 Fair value measurements using input type Level 1 Level 2 Level 3 Total Assets: Available-for-sale marketable securities $ - $ 28,853 $ - $ 28,853 Foreign currency derivative contracts - 650 - 650 Liabilities: Earn-out liability - - - - Foreign currency derivative contracts - (106 ) - (106 ) Total financial net assets $ - $ 29,397 $ - $ 29,397 As of December 31, 2022 Fair value measurements using input type Level 1 Level 2 Level 3 Total Assets: Available-for-sale marketable securities $ - $ 4,293 $ - $ 4,293 Foreign currency derivative contracts - 23 - 23 Liabilities: Earn-out liability - - (656 ) (656 ) Foreign currency derivative contracts - (901 ) - (901 ) Total financial net assets $ - $ 3,415 $ (656 ) $ 2,759 Fair value measurements using significant unobservable inputs (Level 3): Balance at January 1, 2023 $ 656 Earn Out liability – Keepers (656 ) Balance at December 31, 2023 $ - |
DERIVATIVE INSTRUMENTS
DERIVATIVE INSTRUMENTS | 12 Months Ended |
Dec. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
DERIVATIVE INSTRUMENTS | NOTE 5: - DERIVATIVE INSTRUMENTS The Company enters into hedge transactions with a major financial institution, using derivative instruments, primarily forward contracts and options to purchase and sell foreign currencies, in order to reduce the net currency exposure associated with anticipated expenses (primarily salaries and related expenses that are designated as cash flow hedges), trade receivables and forecasted revenues denominated in currencies other than U.S. dollar. The Company currently hedges such future exposures for a maximum period of two years. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons, including but not limited to immateriality, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates. The Company records all derivatives on the consolidated balance sheets at fair value in accordance with ASC No. 820 at Level 2. Cash flow hedges are recorded in other comprehensive income (loss) until the hedged item is recognized in earnings. The Company does not enter into derivative transactions for trading purposes. The net income (loss) recognized in "Financial income (expense), net" during the years ended December 31, 2023, 2022 and 2021 was $(42), $1,520 and $1,272, respectively. The Company had a net unrealized gain (loss) associated with cash flow hedges of $ 482 and $(1,214) recorded in other comprehensive loss as of December 31, 2023 and 2022, respectively. As of December 31, 2023 and 2022, the Company had outstanding hedge transactions in the net amount of $ 17,245 and $ 33,711, respectively. The fair value of the outstanding foreign exchange contracts recorded by the Company on its consolidated balance sheets as of December 31, 2023 and 2022, as assets and liabilities are as follows: Foreign exchange forward and December 31, options contracts Balance sheet 2023 2022 Fair value of foreign exchange hedge transactions Other receivables and prepaid expenses $ 537 $ 12 Fair value of foreign exchange hedge transactions Other payables and accrued expenses (55 ) (838 ) Total derivatives designated as hedging instruments Other Comprehensive profit (loss) $ 482 $ (1,214 ) Gain or loss on the derivative instruments, which partially offset the foreign currency impact from the underlying exposures, reclassified from other comprehensive loss to cost of revenues for the years ended December 31, 2023, 2022 were $ (474) and $ (503), respectively. The amount reclassified from other comprehensive loss to Research and development expenses for the years ended December 31, 2023, 2022 were $ (1,196) and $ (1,955), respectively. The amount reclassified from other comprehensive loss to Sales and marketing expenses for the years ended December 31, 2023, 2022 were $ (540) and $ (1,210), respectively. The amount reclassified from other comprehensive loss to General and administrative expenses for the years ended December 31, 2023, 2022 were $ (440) and $ (509), respectively. Non-designated hedges The Company also uses foreign currency forward contracts to mitigate variability in gains and losses generated from the re-measurement of certain monetary assets and liabilities denominated in foreign currencies. These derivatives do not qualify for special hedge accounting treatment. These derivatives are carried at fair value with changes recorded in financial income, net. Changes in the fair value of these derivatives are largely offset by the re-measurement of the underlying assets and liabilities. The derivatives have maturities of up to twelve months. As of December 31, 2023 and 2022, the Company’s outstanding non-hedge transactions were $ 12,459 and $ 11,949, respectively. The fair value of the outstanding non-designated foreign exchange contracts recorded by the Company on its consolidated balance sheets as of December 31, 2023 and 2022, as assets and liabilities are as follows: Foreign exchange forward and December 31, options contracts Balance sheet 2023 2022 Fair value of foreign exchange non-designated hedge transactions Other receivables and prepaid expenses $ 113 $ 11 Fair value of foreign exchange non-designated hedge transactions Other payables and accrued expenses (51 ) (63 ) Total derivatives non-designated as hedging instruments $ 62 $ (52 ) |
OTHER RECEIVABLES AND PREPAID E
OTHER RECEIVABLES AND PREPAID EXPENSES | 12 Months Ended |
Dec. 31, 2023 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
OTHER RECEIVABLES AND PREPAID EXPENSES | NOTE 6: - OTHER RECEIVABLES AND PREPAID EXPENSES December 31, 2023 2022 Prepaid expenses $ 5,890 $ 4,560 Government authorities 988 2,108 Accrued interest 591 1,059 Foreign currency derivative contracts 650 23 Short-term deposits 145 163 Others 173 72 $ 8,437 $ 7,985 |
INVENTORIES
INVENTORIES | 12 Months Ended |
Dec. 31, 2023 | |
Inventory Disclosure [Abstract] | |
INVENTORIES | NOTE 7: - INVENTORIES December 31, 2023 2022 Raw materials $ 1,656 $ 2,003 Finished goods 10,218 11,259 $ 11,874 $ 13,262 As of December 31, 2023 and 2022, the finished products line item above includes deferral of the cost of goods sold for which revenue was not yet recognized in the amount of approximately $ 1,788 and $ 1,729, respectively. |
PROPERTY AND EQUIPMENT, NET
PROPERTY AND EQUIPMENT, NET | 12 Months Ended |
Dec. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
PROPERTY AND EQUIPMENT, NET | NOTE 8: - PROPERTY AND EQUIPMENT, NET December 31, 2023 2022 Cost: Lab equipment $ 12,750 $ 19,711 Computers and peripheral equipment 11,353 11,856 Office furniture and equipment 1,438 1,568 Leasehold improvements 2,990 3,039 SECaaS equipment 8,036 7,722 36,567 43,896 Accumulated depreciation: Lab equipment 9,835 16,037 Computers and peripheral equipment 9,041 8,239 Office furniture and equipment 535 589 Leasehold improvements 1,692 1,453 SECaaS equipment 4,275 3,342 25,378 29,660 Depreciated cost $ 11,189 $ 14,236 Depreciation expense for the years ended December 31, 2023, 2022 and 2021 was $ 5,536, $ 6,406 and $ 4,635, respectively. |
INTANGIBLE ASSETS, NET
INTANGIBLE ASSETS, NET | 12 Months Ended |
Dec. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
INTANGIBLE ASSETS, NET | NOTE 9: - INTANGIBLE ASSETS, NET a. The following table shows the Company's intangible assets for the periods presented: December 31, 2023 2022 Gross Carrying Amount: Technology $ 10,113 $ 10,113 Backlog 1,877 1,877 Customer relationships 3,592 3,592 Software license 1,651 1,651 IP R&D 3,659 3,659 $ 20,892 $ 20,892 Accumulated amortization: Technology $ 10,113 $ 9,117 Backlog 1,877 1,877 Customer relationships 3,592 3,592 Software license 1,651 660 IP R&D 2,744 2,135 $ 19,977 $ 17,381 Net Carrying Amount: $ 915 $ 3,511 b. Amortization expense for the years ended December 31, 2023, 2022 and 2021 were $ 982, $ 946 and $ 940, respectively. c. Estimated amortization expense for the years ending: Year ending December 31, 2024 $ 610 2025 305 Total $ 915 |
OTHER PAYABLES AND ACCRUED EXPE
OTHER PAYABLES AND ACCRUED EXPENSES | 12 Months Ended |
Dec. 31, 2023 | |
Payables and Accruals [Abstract] | |
OTHER PAYABLES AND ACCRUED EXPENSES | NOTE 10: - OTHER PAYABLES AND ACCRUED EXPENSES December 31, 2023 2022 Accrued expenses $ 5,964 $ 7,056 Deferred revenues from IIA 302 110 Onerous contract liability 551 - Government authorities 2,108 1,955 Foreign currency derivative contracts 106 901 Holdback and contingent earnout 299 1,216 Provision for returns 90 90 Others 108 96 $ 9,528 $ 11,424 |
LEASES
LEASES | 12 Months Ended |
Dec. 31, 2023 | |
Leases [Abstract] | |
LEASES | NOTE 11: - LEASES The Group's facilities are leased under several lease agreements. In addition, the Company has various operating lease agreements with respect to motor vehicles. Lease expenses of office rent and vehicles for the years ended December 31, 2023, 2022 and 2021 were approximately $ 3,545, $ 3,784 and $ 3,141, respectively. Expenses for short- term leases in 2023 were $ 229, $ 82 and $ 92, respectively. Variable lease costs for the years ended December 31, 2023, 2022 and 2021 were $ 831, $ 813 and $732, respectively. The following table represents the weighted-average remaining lease term and discount rate: Year ended December 31, 2023 2022 Weighted average remaining lease term 1.5 years 2.1 years Weighted average discount rate 2.10% 1.49% The discount rate was determined based on the estimated collateralized borrowing rate of the Company, adjusted to the specific lease term and location of each lease. Cash paid for amounts included in measurement of lease liabilities during the years ended 2023, 2022 and 2021 were $4,152, $2,843, and $3,253, respectively. Maturities of operating lease liabilities were as follows: Year ending December 31, 2024 $ 1,465 2025 673 2026 64 Total lease payments 2,202 Less - imputed interest (47 ) Present value of lease liabilities $ 2,155 The Company elected to not recognize a lease liability and a right-of-use (“ROU”) asset for leases with a term of twelve months or less During the years ended December 31, 2023, 2022 and 2021 the short-term maturities of operating lease liabilities with a term of twelve months or less were $ 195, $ 126 and $ 116. |
COMMITMENTS AND CONTINGENT LIAB
COMMITMENTS AND CONTINGENT LIABILITIES | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENT LIABILITIES | NOTE 12: - COMMITMENTS AND CONTINGENT LIABILITIES a. Liens and guarantees: As of December 31, 2023, the Company has provided bank guarantees in respect of performance obligation to customers in an aggregate amount of approximately $ 903, in addition to bank guarantees in favor of leases agreements in an aggregate amount of approximately $ 398. b. Litigations: On November 2, 2021 two founders and six employees of Netonomy Ltd., a company acquired by Allot in January, 2018, filed a civil claim against Allot (the “plaintiffs”), alleging that Allot breached certain clauses of the share acquisition agreement claiming damages in the amount of app. $ 834. Allot has filed its defense statement refuting all claims and denying any breach and obligation to compensate. As of December 31, 2022, the results of this claim were uncertain. On March 6, 2023 the Company signed a settlement agreement with the two founders according to which the Company paid both founders an amount of $ 260 and the founders waived their claim. There are ongoing legal proceedings against the rest. |
SHAREHOLDERS' EQUITY
SHAREHOLDERS' EQUITY | 12 Months Ended |
Dec. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
SHAREHOLDERS' EQUITY | NOTE 13: - SHAREHOLDERS' EQUITY a. Company's shares: As of December 31, 2023, the Company's authorized share capital consists of NIS 20,000,000 divided into 200,000,000 Ordinary Shares, par value NIS 0.1 per share. Ordinary Shares confer on their holders the right to receive notice to participate and vote in general meetings of the Company, the right to a share in the excess of assets upon liquidation of the Company, and the right to receive dividends if declared. b. Share option plan: A summary of the Company's share option activity, pertaining to its option plans for employees and related information is as follows: Year ended December 31, 2023 2022 2021 Number of shares upon exercise Weighted average exercise price Number of shares upon exercise Weighted average exercise price Number of shares upon exercise Weighted average exercise price Outstanding at beginning of year 487,839 $ 5.96 675,986 $ 7.99 1,134,256 $ 7.68 Forfeited (72,480 ) $ 9.04 (139,494 ) $ 16.08 (30,861 ) $ 16.78 Exercised (1,364 ) $ 0.03 (48,653 ) $ 5.01 (427,409 ) $ 6.54 Outstanding at end of year 413,995 $ 5.44 487,839 $ 5.96 675,986 $ 7.99 Exercisable at end of year 413,995 $ 5.44 487,839 $ 5.96 660,986 $ 8.04 Vested and expected to vest 413,995 $ 5.44 487,839 $ 5.96 675,584 $ 7.99 The aggregate intrinsic value represents the total intrinsic value (the difference between the Company's closing share price on the last trading day of the fiscal years 2023, 2022 and 2021 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders if all option holders exercised their options on December 31, 2023, 2022 and 2021, respectively. This amount may change based on the fair market value of the Company's share. The total intrinsic value of options outstanding as of December 31, 2023, 2022 and 2021, were $ 0, $ 10 and $ 3,481, respectively. The total intrinsic value of exercisable options as of December 31, 2023, 2022 and 2021, were approximately $ 1, $ 10 and $ 3,392 , respectively. The total intrinsic value of options vested and expected to vest as of December 31, 2023, 2022 and 2021, were approximately $ 0, $ 10 and $ 3,479, respectively. The total intrinsic value of options outstanding as of December 31, 2023, 2022 and 2021, were approximately $ 0, $ 10 and $ 3,481, respectively. The total intrinsic value (the difference between the Company's closing share price on the exercise date and the exercise price) of options exercised during the years ended December 31, 2023, 2022 and 2021 were approximately $ 93, $ 93 and $ 4,113 , respectively. The number of options vested during the year ended December 31, 2023, was 0. The weighted-average remaining contractual life of the outstanding options as of December 31, 2023, is 0.51 years. The weighted-average remaining contractual life of exercisable options as of December 31, 2023, is 0.51 years. The following provides a summary of the restricted share unit activity for the Company for the two years ended December 31, 2023: Year ended December 31, 2023 2022 Number of shares upon exercise Weighted average share price Number of shares upon exercise Weighted average share price Outstanding at beginning of year 2,255,620 $ 8.52 1,937,908 $ 12.92 Granted 1,330,500 $ 2.47 1,473,400 $ 5.22 Vested (1,005,532 ) $ 2.19 (829,910 ) $ 15.82 Forfeited (316,889 ) $ 2.38 (325,778 ) $ 5.78 Unvested at end of year 2,263,699 $ 4.95 2,255,620 $ 8.52 As of December 31, 2023, $ 8,134,803 unrecognized compensation cost related to RSUs is expected to be recognized over a weighted average vesting period of 1.62 years. Under the terms of the above option plans, options may be granted to employees, officers, directors and various service providers of the Company and its subsidiaries. The options vest over a four-year period, subject to the continued employment of the employee. The options generally expire no later than ten years from the date of the grant. The exercise price of the options at the date of grant under the plans may not be less than the nominal value of the shares into which such options are exercised, any options, which are forfeited or cancelled before expiration, become available for future grants. As of December 31, 2023, 252,548 Ordinary shares are available for future issuance under the option plans. The Company granted 1,330,500 and 1,473,400 RSUs in 2023 and 2022, respectively under the 2016 option plan. RSUs vest over a period of between three |
TAXES ON INCOME
TAXES ON INCOME | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
TAXES ON INCOME | NOTE 14: - TAXES ON INCOME a. Corporate tax rates: The Israeli corporate income tax rate was 23% in 2023, 2022 and 2021. b. Foreign Exchange Regulations: Commencing in taxable year 2012, the Company has elected to measure its taxable income and file its tax return under the Israeli Income Tax Regulations (Principles Regarding the Management of Books of Account of Foreign Invested Companies and Certain Partnerships and the Determination of Their Taxable Income) 1986 ("Foreign Exchange Regulations"). Under the Foreign Exchange Regulations, an Israeli company must calculate its tax liability in U.S. Dollars according to certain rules. The tax liability, as calculated in U.S. Dollars is translated into NIS according to the exchange rate as of December 31st of each year. c. Pre-tax income (loss) is comprised as follows: Year ended December 31, 2023 2022 2021 Domestic $ (64,360 ) $ (32,826 ) $ (15,419 ) Foreign 2,640 2,691 2,230 $ (61,720 ) $ (30,135 ) $ (13,189 ) d. A reconciliation of the theoretical tax expenses, assuming all income is taxed at the statutory tax rate applicable to the income of the Company and the actual tax expenses is as follows: Year ended December 31, 2023 2022 2021 Loss before taxes on income $ (61,720 ) $ (30,135 ) $ (13,189 ) Theoretical tax income computed at the Israeli statutory tax rate (23% for the years 2023, 2022 and 2021, respectively) $ (14,196 ) $ (6,931 ) $ (3,034 ) Changes in valuation allowance 13,131 4,116 2,604 Write off of prepaid and withholding taxes 749 1,388 875 Foreign tax rates differences related to subsidiaries 20 46 14 Non-deductible expenses and exempt income (269 ) 512 71 Capital note and inter-company balances release taxes - 544 100 Other expenses and Exchange rate differences ( 37 ) 195 488 Non-deductible share-based compensation expense 1,586 1,925 633 Change in uncertain tax positions 100 100 100 Actual tax expense $ 1,084 $ 1,895 $ 1,851 e. Taxes on income Income tax expense is comprised as follows: Year ended December 31, 2023 2022 2021 Current taxes $ 248 $ 391 $ 334 Deferred taxes expense - - 420 Taxes in respect of previous years (13 ) 16 122 Write off of prepaid and withholding taxes 749 1,388 875 Change in expense associated with tax positions for current year 100 100 100 $ 1,084 $ 1,895 $ 1,851 Taxes on income by jurisdiction were as follows: Year ended December 31, 2023 2022 2021 Domestic $ 822 $ 1,129 $ 973 Foreign 262 766 878 Total $ 1,084 $ 1,895 $ 1,851 Domestic Taxes in respect of previous years $ - $ (20 ) $ 37 Write off of prepaid and withholding taxes 822 1,149 936 Total Domestic $ 822 $ 1,129 $ 973 Foreign Current taxes $ 248 $ 391 $ 334 Deferred taxes expense - - 420 Taxes in respect of previous years (13 ) 36 85 Write off of prepaid and withholding taxes (73 ) 239 (61 ) Change in expense associated with tax positions for current year 100 100 100 Total foreign $ 262 $ 766 $ 878 Total income tax expense (benefit) $ 1,084 $ 1,895 $ 1,851 f. Net operating losses carry forward: The Company has accumulated net operating losses for Israeli tax purposes as of December 31, 2023, in the amount of approximately $ 118,905, which may be carried forward and offset against taxable income in the future for an indefinite period. As of December 31, 2023, the Company recorded a full valuation allowance with respect to its net deferred tax assets in Allot Ltd. and wrote-off prepaid and withholding taxes of $ 6,297 as the Company does not expect to utilize these tax assets in the near future. In addition, the Company has accumulated capital losses for tax purposes as of December 31, 2023, of approximately $ 27,191, which may be carried forward and offset against taxable capital gains in the future for an indefinite period. Management currently believes that since the Company has a history of losses, and uncertainty with respect to future taxable income, it is more likely than not that the deferred tax assets regarding the loss carry forwards will not be utilized in the foreseeable future. Thus, a valuation allowance was provided to reduce deferred tax assets to their realizable value. The U.S. subsidiary has accumulated losses for U.S. federal income tax return purposes of approximately $ 1,615 and $ 5,414 for state taxes. The federal accumulated losses for tax purposes expire between 2027 2038 A portion of the losses are subject to limitations of Internal Revenue Code, Section 382, which in general provides that utilization of net operating losses is subject to an annual limitation if an ownership change results from transactions increasing the ownership of certain shareholders or public groups in the share of a corporation by more than 50 percentage points over a three-year period. The annual limitations may result in the expiration of losses before utilization. g. Deferred income taxes: Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred income taxes are as follows: December 31, 2023 2022 Deferred tax assets: Operating and capital loss carryforwards $ 34,420 $ 25,962 Research and development 8,423 10,260 Employee benefits 1,522 1,286 Intangible assets 353 77 Operating lease liabilities 496 1,178 Stock based compensation expenses 1,733 1,481 Onerous contract 127 - Prepaid and withholding taxes 6,297 5,702 Other temporary differences 543 563 Deferred tax asset before valuation allowance 53,914 46,509 Valuation allowance (49,928 ) (41,917 ) Deferred tax asset net of valuation allowance 3,986 4,592 Deferred tax liability: Intangible assets 3,284 3,354 Operating lease right-of-use assets 702 1,239 Net deferred tax asset $ - $ - A s of December 31, 2023, the Company has provided a valuation allowance of approximately $50 million in respect of the Company’s deferred tax assets resulting from tax loss carryforwards and other temporary differences. Realization of deferred tax assets is dependent upon future earnings, if any, the time and amount of which are uncertain. As the Company has accumulated net operating losses for Israeli tax purposes as of December 31, 2023, in the amount of approximately $118,905, so it is more likely than not that sufficient taxable income will not be available for the tax losses to be utilized in the future. Therefore, a valuation allowance was recorded to reduce the deferred tax assets to nil. Non-Israeli subsidiaries are taxed according to the tax laws in their respective countries of residence. Deferred taxes were not provided for undistributed earnings of the Company’s foreign subsidiaries. Currently, the Company does not intend to distribute any amounts of its undistributed earnings as dividends. Accordingly, no deferred income taxes have been provided in respect of these subsidiaries. If these earnings were distributed to Israel in the form of dividends or otherwise, the Company would be subject to additional Israeli income taxes (subject to an adjustment for foreign tax credits) and foreign withholding taxes. As of December 31, 2023, $ 5,220 of undistributed earnings held by the Company’s foreign subsidiaries are designated as indefinitely reinvested. If these earnings were re-patriated to Israel, they would be subject to income taxes and to an adjustment for foreign tax credits and foreign withholding taxes in the amount of $771. The Company did not recognize deferred taxes liabilities on undistributed earnings of its foreign subsidiaries, as the Company intends to indefinitely reinvest those earnings. h. As of December 31, 2023 and 2022, the Company have an outstanding provision for uncertain tax position in the amount of $ 1,043 and $ 943, respectively. The Company conducts business globally and, as a result, the Company or one or more of its subsidiaries file income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities throughout the world, including such major jurisdictions as Israel, France, Spain, Japan and the United States. With a few exceptions, the Company is no longer subject to Israeli tax assessment through the year 2020 and the Spanish and U.S. subsidiaries have final tax assessments through 2018 and 2019, respectively. |
GEOGRAPHIC INFORMATION
GEOGRAPHIC INFORMATION | 12 Months Ended |
Dec. 31, 2023 | |
Segment Reporting [Abstract] | |
GEOGRAPHIC INFORMATION | NOTE 15: - GEOGRAPHIC INFORMATION Allot operates in a single reportable segment. Revenues are based on the location of the Company's channel partners which are considered as end customers, as well as direct customers of the Company: Year ended December 31, 2023 2022 2021 Europe $ 39,945 $ 41,773 $ 58,414 Asia and Oceania 20,547 29,888 44,227 Americas 16,542 21,791 19,391 Middle East and Africa (*) 16,116 29,285 23,568 $ 93,150 $ 122,737 $ 145,600 (*) As of December 31, 2023, 2022 and 2021, 1% from total revenues represent revenues in Israel The following table sets forth the customers that represented 10% or more of the Company’s total revenues in each of the periods set forth below: Year ended December 31, 2023 2022 2021 1 st 15 % - 11 % 15 % - 11 % A total percentage of 77%, 77% and 72% of the Company’s revenues for the years ended December 31, 2023, 2022 and 2021, respectively are attributed to network intelligence solutions, while 23%, 23% and 28% are attributed to security solutions for the years ended December 31, 2023, 2022 and 2021, respectively. The following presents total long-lived assets, including right-of-use assts, as of December 31, 2023 and 2022: December 31, 2023 2022 Long-lived assets: Israel $ 13,431 $ 18,472 Other 815 1,151 $ 14,246 $ 19,623 |
FINANCIAL INCOME (EXPENSES), NE
FINANCIAL INCOME (EXPENSES), NET | 12 Months Ended |
Dec. 31, 2023 | |
Other Income and Expenses [Abstract] | |
FINANCIAL INCOME (EXPENSES), NET | NOTE 16: - FINANCIAL INCOME (EXPENSES), NET Year ended December 31, 2023 2022 2021 Financial income: Interest income $ 2,341 $ 1,880 $ 1,045 Amortization/accretion of premium/discount on marketable securities, net 732 - - Exchange rate differences and other 214 292 - Financial expenses: Exchange rate differences and other - - 630 institutions interest Expenses 72 - - Amortization/accretion of premium/discount on marketable securities, net - 38 76 $ 3,215 $ 2,134 $ 339 |
RELATED PARTIES BALANCES AND TR
RELATED PARTIES BALANCES AND TRANSACTIONS | 12 Months Ended |
Dec. 31, 2023 | |
Related Party Transactions [Abstract] | |
RELATED PARTIES BALANCES AND TRANSACTIONS | NOTE 17: - RELATED PARTIES BALANCES AND TRANSACTIONS a. The Company acquired services from Galil Software Ltd. (“Galil”), a related party as part of a service agreement between them which was approved by the board of directors of the Company. Galil is owned by a member of the board of directors of the Company. The Company recorded expenses related to services received from Galil amounting to approximately $ 325 and $ 993 for the years ended December 31, 2023 and 2022, respectively. In addition, as of December 31, 2023 and 2022, the Company had outstanding balances due to Galil in amounts of $ 24 and $ 93, respectively.these balances are presented in other payables account on the balance sheet. b. Lynrock Lake Master Fund LP (“Lynrock”) is a Major Sharholder of the Company’s ordinary shares as of December 31, 2023 and 2022. As of December 31, 2023, the Company had an outstanding senior unsecured promissory note in an aggregate principal amount of $ 40,000 (the “Note”) issued to Linrock, see note 18 below. The Company recorded amortization expenses related to the issuance costs of the notes during the years ended December 31, 2023 and 2022, in amountes of $ 198 and $ 171, respectively. In addition, as of December 31, 2023 and 2022, the Company had Convertible debt balances due to its Note in amounts of approximately $ 39,773 and $ 39,575, respectively. |
CONVERTIBLE NOTES
CONVERTIBLE NOTES | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Convertible Notes | NOTE 18: - CONVERTIBLE NOTES On February 14, 2022, the Company issued to Lynrock a senior unsecured promissory note in an aggregate principal amount of $ 40,000. The Note is convertible into the company's ordinary shares at an initial conversion rate of 97.0874 ordinary shares per $1,000 of the principal amount being converted (based on an initial conversion price equal to $10.30 per ordinary share). The conversion price decreases by up to two $1 increments if the company elects to extend the maturity of the Note by up to two successive years following the initial maturity date of February 14, 2025. In event of a change of control (as defined in the note), the holder of the note has the right to require the company to convert all or a portion of the note to ordinary shares or redeem all (but not less than all) of the outstanding principal amount of the note. In the event of such a conversion or redemption in connection with a change in control, the company will also be required to pay the holder an amount in cash equal to 6% per annum on the then-outstanding principal amount of the note from the date of such conversion or redemption trough the maturity date, as it may have been extended. The Convertible Notes consisted of the following as of December 31, 2023 and 2022: December 31, 2023 2022 Liability: Principal $ 40,000 $ 40,000 Unamortized issuance costs (227 ) (425 ) Net carrying amount $ 39,773 $ 39,575 As of the issuing date, the company recorded the issuance costs related to the Note in amount of $596 as a deduction of the liability which will be amortized over 3 years with an annual effective interest rate of the net liability is 0.14%. The company recorded amortization expenses related to the issuance costs during the years ended December 31, 2023 and 2022 in amountes of $ 198 and $ 171, respectively. |
SIGNIFICANT ACCOUNTING POLICI_2
SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Use of estimates | a. Use of estimates: The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. |
Financial statements in U.S. dollars | b. Financial statements in U.S. dollars: The majority operation of the Company and its subsidiaries are generated in U.S. dollars ("dollar") or linked to the dollar. The Company's management believes that the dollar is the currency of the primary economic environment in which the Company and its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the dollar. Accordingly, monetary accounts maintained in currencies other than the dollar are remeasured into U.S. dollars in accordance with Accounting Standards Codification No. 830, "Foreign Currency Matters" ("ASC No. 830"). All transactions gains and losses from the remeasurement of monetary balance sheet items are reflected in the statements of operations as financial income or expenses as appropriate. Financial gains and (losses) related to exchange rate differences in connection with revaluation of assets and liabilities in non-dollar denominated currencies for the years ended December 31, 2023, 2022, and 2021 amounted to $ 378, $ 442 and $ (454), respectively. |
Principles of consolidation | c. Principles of consolidation: The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated upon consolidation. |
Cash and cash equivalents | d. Cash and cash equivalents: The Company considers all unrestricted highly liquid investments which are readily convertible into cash, with a maturity of three months or less at the date of acquisition, to be cash equivalents. |
Restricted deposits | e. Restricted deposits: Restricted deposits consists of depoisits used as security for the company’s transactions with customers, hedging transactions and lease agreements. As of December 31, 2023 and 2022, restricted deposits were mainly denominated in U.S. dollars, amounted to $ 1,886 and $1,050, respectively, and bore a weighted average interest rate of 4.77% and 5.55%, respectively. |
Short-term bank deposits | f. Short-term bank deposits: Short-term bank deposits are deposits with maturities of more than three months but less than one year at the balance sheet date. The deposits are in dollars and bear interest at an annual weighted average rate of 6.58% and 4.05% on December 31, 2023 and 2022, respectively. |
Trade Receivable and Allowances | g. Trade Receivable and Allowances: Trade receivables are recorded and carried at the original invoiced amount which was recognized as revenues less an allowance for any potential uncollectible amounts. The Company makes estimates of expected credit losses for the allowance for credit losses and allowance for unbilled receivables based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The estimated credit loss allowance is recorded as general and administrative expenses on the Company’s consolidated statements of income (loss). The following table displays a rollforward of the total allowance for credit losses for the years ended December 31, 2023, 2022, and 2021. 2023 2022 2021 Total allowance for credit losses – January 1 2,908 2,398 2,309 Current-period provision for expected credit losses 22,563 823 293 Write-offs (145 ) (64 ) (9 ) Recoveries collected (73 ) (249 ) (195 ) Total allowance for credit losses – December 31 25,253 2,908 2,398 During 2023, the Company recognized $ 22,563 increase in the credit losses provision. This increase was primarily due to management’s estimation regarding the deterioration in the economic conditions of four customers, mainly in Africa, during 2023 and their ability to repay their outstanding debt. |
Marketable securities | h. Marketable securities: Marketable securities consist mainly of government bonds. The Company determines the appropriate classification of marketable securities at the time of purchase and re-evaluates such designation at each balance sheet date. In accordance with FASB ASC No. 320 “Investments- Debt and Equity Securities,” the Company classifies marketable securities as available-for-sale. Available-for-sale securities are stated at fair value, with unrealized gains and losses reported in accumulated other comprehensive income (loss), a separate component of shareholders’ equity, net of taxes. Realized gains and losses on sales of marketable securities, as determined on a specific identification basis, are included in financial income, net. The amortized cost of marketable securities is adjusted for amortization of premium and accretion of discount to maturity, both of which, together with interest, are included in financial income, net. The Company has classified all marketable securities as short-term, even though the stated maturity date may be one year or more beyond the current balance sheet date, because it is probable that the Company will sell these securities prior to maturity to meet liquidity needs or as part of risk versus reward objectives. Available-for-sale debt securities with an amortized cost basis in excess of estimated fair value are assessed to determine what amount of that difference, if any, is caused by expected credit losses. The Company periodically evaluates its available-for-sale debt securities for impairment. If the amortized cost of an individual security exceeds its fair value, the Company considers its intent to sell the security or whether it is more likely than not that it will be required to sell the security before recovery of its amortized basis. If either of these criteria are met, the Company writes down the security to its fair value and records the impairment charge in interest and other income, net in the Consolidated Statements of Operations. If neither of these criteria are met, the Company determines whether credit loss exists. Expected credit losses on available-for-sale debt securities are recognized in interest and other income (expense), net, on the Company’s consolidated statements of income (loss), and any remaining unrealized losses, net of taxes, are included in accumulated other comprehensive income (loss) in Shareholder's equity. As of December 31, 2023 and 2022, no credit loss impairment was recorded regarding the available for sale marketable securities. |
Inventories | i. Inventories: Inventories are stated at the lower of cost or net realizable value. Inventory write-offs are provided to cover risks arising primarily from end of life products and from slow-moving items, technological obsolescence, and excess inventory. Inventory net write-offs during the years ended December 31, 2023, 2022 and 2021 amounted to $ 1,558, $ 905 and $ 4,593, respectively, and were recorded in cost of revenues. Provision for slow moving inventory as of December 31, 2023 and 2022 amounted to $ 8,895 and $ 8,862, respectively. Inventory cost is determined using the weighted average cost method. |
Property and equipment, net | j. Property and equipment, net: Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets at the following annual rates: % Lab equipment 16 - 25 Computers and peripheral equipment 33 Office furniture 6 SECaaS equipment * 16 Leasehold improvements Over the shorter of the term of the lease or the useful life of the asset * SECaaS equipment – the equipment used for SECaaS revenues |
Goodwill | k. Goodwill: Goodwill represents the excess of the purchase price over the fair value of net assets of purchased businesses. Under Accounting Standards Codification No. 350, "Intangibles-Goodwill and Other" ("ASC No. 350"), goodwill is not amortized, but rather subject to an annual impairment test, or more often if there are indicators of impairment present. In accordance with ASC No. 350 the Company performs an annual impairment test at December 31 each year. ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If the Company elects not to use this option, or if the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company prepares a quantitative analysis to determine whether the carrying value of reporting unit exceeds its estimated fair value. If the carrying value of a reporting unit exceeds its estimated fair value, the Company recognizes an impairment of goodwill for the amount of this excess. The Company operates in one operating segment, and this segment comprises its only reporting unit. The Company has performed an annual impairment analysis as of December 31, 2023 and determined that the carrying value of the reporting unit was lower than the fair value of the reporting unit. Fair value is determined using market value. During the years 2023, 2022 and 2021, no impairment losses were recorded. |
Impairment of long-lived assets, Right-of-use assets, and intangible assets subject to amortization | l. Impairment of long-lived assets, Right-of-use assets, and intangible assets subject to amortization: Property and equipment, Right-of-use assets, and intangible assets subject to amortization are reviewed for impairment in accordance with ASC No. 360, "Accounting for the Impairment or Disposal of Long-Lived Assets," whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Intangible assets acquired in a business combination are recorded at fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives. Some of the acquired intangible assets are amortized over their estimated useful lives in proportion to the economic benefits realized. This accounting policy results in accelerated amortization of such customer relationships as compared to the straight-line method. All other intangible assets are amortized over their estimated useful lives on a straight-line basis. The Company has performed an annual impairment analysis as of December 31, 2023 and determined that there were circumstances indicating the asset’s carrying value may not be recoverable. During the year 2023, impairment losses were recorded in the amount of $ 1,614. During the years 2022 and 2021, no impairment losses were recorded. |
Revenue recognition | m. Revenue recognition: The Company generates revenues mainly from selling its products along with related maintenance and support services. At times, these arrangements may also include professional services, such as installation services or training. Some of the Company’s product sales are through resellers, distributors, OEMs and system integrators, all of whom are considered end-users. The Company also generates revenues from services, in which the Company provides network filtering and security services to its customers. The Company recognizes revenue under the core principle that transfer of control to the Company’s customers should be depicted in an amount reflecting the consideration the Company expects to receive. As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation. Some of the Company's contracts usually include combinations of products and services, that are capable of being distinct and accounted for as separate performance obligations. The products are distinct as the customer can derive the economic benefit of it without any professional services, updates or technical support. The Company allocates the transaction price to each performance obligation based on its relative standalone selling price out of the total consideration of the contract. For support, the Company determines the standalone selling prices based on the price at which the Company separately sells a renewal support contract on a stand-alone basis. For professional services, the Company determines the standalone selling prices based on the price at which the Company separately sells those services on a stand-alone basis. If the standalone selling price is not observable, the Company estimates the standalone selling price by taking into account available information such as geographic or regional specific factors, internal costs, profit objectives, and internally approved pricing guidelines related to the performance obligation. Product revenue is recognized at a point in time when the performance obligation is being satisfied. Maintenance and support related revenues are deferred and recognized on a straight-line basis over the term of the applicable maintenance and support agreement. Professional services are usually recognized at a point in time when the performance obligation is being satisfied. The Company elected the practical expedient to not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised goods or services to the customer will be one year or less. In certain contracts, the Company provides the customer with financing for a period exceeding the regular credit terms for customers. In such circumstances, the Company recognizes revenue based on the amount that reflects the price that would have been paid by the customer in cash on the date of receipt of the goods or services, and the balance is recognized in finance income. The Company also enters service contracts, in which the Company provides security as a service (SECaaS) solution to operators, which the Company considers as its customers. The Company's security as a service solution is offered to operators on a Revenue Share business model, where both the Company and the operator share the revenue generated from the operator's subscribers or a monthly fee per user. Most of the Company's security as a service contracts contain a single performance obligation comprised of series of distinct goods and services satisfied over time. The contracts consideration is based on usage by the operator's subscribers. As such, the Company allocates the variable consideration in those contracts to distinct service periods in which the service is provided and recognizes revenue for each distinct service period. Deferred revenue includes amounts received from customers for which revenue has not yet been recognized. Deferred revenues are classified as short and long-term based on their contractual term and recognized as (or when) the Company performs under the contract. The portion of the transaction price allocated to remaining performance obligations represents contracts that have not yet been recognized that include deferred revenue and amounts not yet received that will be recognized as revenue in future periods. As of December 31, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations that the Company expects to recognize is $ 59 million of which approximately $ 39 million is estimated to be recognized before December 31, 2024 and approximately $ 20 million is estimated to be recognized after December 31, 2024. The Company pays sales commissions to sales and marketing personnel based on their certain predetermined sales goals. The company evaluates its commission and capitalize only incremental commissions costs which are considered recoverable costs of obtaining a contract with a customer. These capitalized sales commissions costs are amortized over a period of benefit which is typically over the term of the customer contracts as initial commission rates are commensurate with the renewal commission rates. Amortization expenses related to these costs are included in sales and marketing expenses in the consolidated statements of operations. For the year ended December 31, 2023 and December 31, 2022 , the deferred commission was $1,572 and $1,863 accordingly. The amortization of deferred commission for 2023, 2022 and 2021 were $1,239, $1,296 and $1,394. The Company uses the practical expedient and does not assess the existence of a significant financing component when the difference between payment and revenue recognition is a year or less. The Company estimated variable consideration related to product returns based on its experience with historical product returns and other known factors. Such provisions amounted to $90 and $90 as of December 31, 2023 and 2022, respectively. As of December 31, 2023 and 2022, this provision was recorded as part of other payables and accrued expenses. The Company recognizes term-based license agreements at the point in time when control transfers and the associated maintenance revenues over the contract period. |
Cost of revenues | n. Cost of revenues: Cost of revenues consists primarily of costs of materials and the cost of maintenance and services, resulting from costs associated with support, customer success and professional services. |
Research and development costs | o. Research and development costs: Accounting Standards Codification No. 985-20, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility. Based on the Company's product development process, technological feasibility is established upon the completion of a working model. The Company does not incur material costs between the completion of a working model and the point at which the products are ready for general release. Therefore, research and development costs are charged to the consolidated statement of comprehensive loss as incurred. |
Severance pay | p. Severance pay: The liability in Israel for substantially all of the Company`s employees in respect of severance pay liability is calculated in accordance with Section 14 of the Severance Pay Law -1963 (herein- "Section 14"). Section 14 states that Company's contributions for severance pay shall be in line of severance compensation and upon release of the policy to the employee, no additional obligations shall be conducted between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. Furthermore, the related obligation and amounts deposited on behalf of such obligation under Section 14, are not stated on the balance sheet, because pursuant to the current ruling, they are legally released from the obligation to employees once the deposits have been paid. There are a limited number of employees in Israel, for whom the Company is liable for severance pay. The Company's liability for severance pay for its Israeli employees was calculated pursuant to Section 14, based on the most recent monthly salary of its Israeli employees multiplied by the number of years of employment as of the balance sheet date for such employees. The Company's liability was partly provided by monthly deposits with severance pay funds and insurance policies and the remainder by an accrual. Severance expense for the years ended December 31, 2023, 2022 and 2021, amounted to $ 6,057, $ 3,516 and $ 2,456, respectively. During 2023, the Company implemented a cost reduction plan which included separation of employees which derived the 2023 severance exepenses. |
Accounting for share-based compensation | q. Accounting for share-based compensation: The Company accounts for share-based compensation in accordance with Accounting Standards Codification No. 718, "Compensation - Stock Compensation" ("ASC No. 718") that requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated statement of comprehensive loss. For graded vesting with only service condition the Company recognizes compensation expenses for the value of its awards based on the straight-line method over the requisite service period of each of the awards, net of estimated forfeitures. A modification to the terms of an award should be treated as an exchange of the original award for a new award with total compensation cost equal to the grant-date fair value of the original award plus the incremental value measured at the same date. Under ASC 718, the calculation of the incremental value is based on the excess of the fair value of the new (modified) award based on current circumstances over the fair value of the original award measured immediately before its terms are modified based on current circumstances. The Company estimated the forfeiture rate based on historical forfeitures of equity awards and adjusted the rate to reflect changes in facts and circumstances if any. The following table sets forth the total share-based compensation expense resulting from share options, restricted share units and Phantoms granted to employees included in the consolidated statements of comprehensive loss, for the years ended December 31, 2023, 2022 and 2021: Year ended December 31, 2023 2022 2021 Cost of revenues $ 1,219 $ 1,133 $ 581 Research and development 3,010 3,168 2,499 Sales and marketing 2,651 2,943 3,212 General and administrative 1,965 1,921 1,708 Total share-based compensation expense $ 8,845 $ 9,165 $ 8,000 During 2023, 2022 and 2021 no options were granted by the Company. The computations of expected volatility and suboptimal exercise multiple is based on the average of the Company's realized historical share price. The computation of the suboptimal exercise multiple and the forfeiture rates are based on the grantee's expected exercise prior and post vesting termination behavior. The interest rate for a period within the contractual life of the award is based on the U.S. Treasury Bills yield curve in effect at the time of grant. The Company currently has no plans to distribute dividends and intends to retain future earnings to finance the development of its business. The expected life of the share options represents the weighted-average period the share options are expected to remain outstanding and is a derived output of the binomial model. The expected life of the share options is impacted by all of the underlying assumptions used in the Company's model. The option pricing model of the of restricted share units ("RSUs") is based on the closing market value of the underlying shares at the date of grant. The expected annual pre-vesting forfeiture rate affects the number of vested RSUs. Based on the Company's historical experience, the pre-vesting is in the range of 0%-30% in the years 2023, 2022 and 2021. |
Treasury share | r. Treasury share: In the past, the Company repurchased its Ordinary shares on the open market and holds such shares as treasury share. The Company presents the cost to repurchase treasury share as a reduction of shareholders' equity. |
Concentration of credit risks | s. Concentration of credit risks: Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, short-term bank deposits, trade receivables and derivative instruments. The majority of cash and cash equivalents and short-term deposits of the Company are invested in dollar deposits in major U.S. and Israeli banks. Such investments in the United States may be in excess of insured limits and are not insured in other jurisdictions. Generally, the cash and cash equivalents and short-term bank deposits may be redeemed upon demand, and therefore, bear minimal risk. Marketable securities include investments in Dollar linked corporate and government bonds. Marketable securities consist of highly liquid debt instruments with high credit standing. The Company’s investment policy, approved by the Board of Directors, limits the amount the Group may invest in any one type of investment or issuer, thereby reducing credit risk concentrations. Management believes that the portfolio is well diversified and, accordingly, minimal credit risk exists with respect to these marketable debt securities. The Company's trade receivables are derived from sales to customers located in EMEA, as well as in APAC, Latin America and the United States. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers and establishes an allowance for credit losses on a specific basis. Allowance for credit losses amounted to $ 25,253 and $ 2,908 as of December 31, 2023 and 2022, respectively. See note 2g above. As of 31.12.2023 we have past due of $2 million. The Company utilizes foreign currency forward contracts to protect against risk of overall changes in exchange rates for some of its currencies exposure. The derivative instruments hedge a portion of the Company's non-dollar currency exposure. Counterparties to the Company’s derivative instruments are all major financial institutions and its exposure is limited to the amount of any asset resulting from the forward contracts. |
Government grants | t. Government grants: Grants from the Israel Innovation Authority (IIA): Participation grants from the Israel Innovation Authority (Previously known as the Office of the Chief Scientist) for research and development activity are recognized at the time the Company is entitled to such grants on the basis of the costs incurred and included as a deduction of research and development costs. Research and development non royalty bearing grants recognized amounted to $ 552, $ 539 and $ (42) in 2023, 2022 and 2021, respectively. Grants from the Spain Tax Authorities: Participation grants from the Spain Tax Authorities for research and development activity are recognized at the time the Company is entitled to such grants on the basis of the costs incurred and included as a deduction of research and development costs. Research and development non royalty bearing grants recognized amounted to $ 2,577 and $ 286 in 2023 ,2022 respectively. |
Income taxes | u. Income taxes: The Company accounts for income taxes in accordance with Accounting Standards Codification No. 740, "Income Taxes" ("ASC No. 740"). ASC No. 740 prescribes the use of the liability method, whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that some portion or all of the deferred tax assets will not be realized. The deferred tax assets and liabilities are classified to non-current assets and liabilities, respectively. ASC No. 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income. |
Basic and diluted net income (loss) per share | v. Basic and diluted net income (loss) per share: Basic net income (loss) per share is computed based on the weighted average number of Ordinary Shares outstanding during each year. Diluted net income (loss) per share is computed based on the weighted average number of Ordinary Shares outstanding during each year, plus dilutive potential Ordinary Shares considered outstanding during the year, in accordance with FASB ASC 260 "Earnings Per Share". For the years ended December 31, 2023, 2022 and 2021, all outstanding options and RSUs have been excluded from the calculation of the diluted net loss per share since their effect was anti-dilutive. The amount of those options and RSU’s was: 2,665,194, 2,735,125, 2,613,894 respectively. |
Comprehensive loss | w. Comprehensive loss: The Company accounts for comprehensive loss in accordance with Accounting Standards Codification No. 220, "Comprehensive Income" ("ASC No. 220"). This statement establishes standards for the reporting and display of comprehensive loss and its components in a full set of general The following table shows the components and the effects on net loss of amounts reclassified from accumulated other comprehensive loss as of December 31, 2023: Year ended December 31, 2023 Unrealized gain (losses) on marketable securities Unrealized gains (losses) on cash flow hedges Total Balance as of December 31, 2022 $ (40 ) $ (1,214 ) $ (1,254 ) Changes in other comprehensive loss before reclassifications 41 (960 ) (919 ) Amounts reclassified from accumulated other comprehensive loss to: Cost of revenues - 475 475 Research and development - 1,198 1,198 Sales and marketing - 542 542 General and administrative - 441 441 Net current-period other comprehensive loss 41 1,696 1,737 Balance as of December 31, 2023 $ 1 $ 482 $ 483 There was no income tax expense or benefit allocated to other comprehensive income, including reclassification adjustments for the year ended December 31, 2023. |
Fair value of financial instruments | x. Fair value of financial instruments: The carrying amounts of short-term bank deposits, trade receivables, other receivables, trade payables and other payables approximate their fair value due to the short-term maturities of such instruments. The Company measures its cash and cash equivalents, marketable securities, derivative instruments and earn-out considerations at fair value. Fair value is an exit price, representing the amount that would be received if the Company were to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. The Company uses a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value: Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 - Include other inputs that are directly or indirectly observable in the marketplace, other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets with insufficient volume or infrequent transactions, or other inputs that are observable (model-derived valuations in which significant inputs are observable), or can be derived principally from or corroborated by observable market data; and Level 3 - Unobservable inputs which are supported by little or no market activity. The Company categorized each of its fair value measurements in one of those three levels of hierarchy. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company measures its marketable securities and foreign currency derivative contracts at fair value. Marketable securities and foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments. The Company's earn-out considerations were classified within Level 3. This year, the valuation methodology used by the Company to calculate the fair value consideration is the discounted cash flow using purchase method by taking into account, forecast future revenues. According to the management there are no estimation for future revenues and therefore the earn-out fair value measurement is nil. As of December 31, 2022 the fair value of the earn-out was $ 656. |
Derivatives and hedging | y. Derivatives and hedging: The Company accounts for derivatives and hedging based on Accounting Standards Codification No. 815, "Derivatives and Hedging" ("ASC No. 815"). The Company accounts for its derivative instruments as either assets or liabilities and carries them at fair value. Derivative instruments that are not designated and qualified as hedging instruments must be adjusted to fair value through earnings. For highly effective derivative instruments that hedge the exposure to variability in expected future cash flows that are designated as cash flow hedges. Gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income (loss) in shareholders' equity and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. |
Business combinations | z. Business combinations: The Company accounts for business combinations in accordance with ASC No. 805. ASC No. 805 requires recognition of assets acquired, liabilities assumed, and any non-controlling interest at the acquisition date, measured at their fair values as of that date. Any excess of the fair value of net assets acquired over the purchase price is recorded as goodwill and any subsequent changes in estimated contingencies are to be recorded in earnings. In addition, changes in valuation allowance related to acquired deferred tax assets and acquired income tax positions are to be recognized in earnings. |
Lease | aa. Lease: The Company determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of an identified asset, (2) whether the Company obtains the right to substantially all the economic benefits from the use of the asset throughout lease period, and (3) whether the Company has a right to direct the use of the asset. The Company elected to not recognize a lease liability and a right-of-use (“ROU”) asset for leases with a term of twelve months or less. The Company also elected the practical expedient to not separate lease and non-lease components for its leases. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease. ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the company's operating leases is generally not determinable, therefore the Company uses it’s Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Company’s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company will not exercise the option. Payments under our lease arrangements are primarily fixed, however, certain lease agreements include rental payments that are adjusted periodically for the consumer price index ("CPI"). The ROU and lease liability were calculated using the CPI as of the commencement date and will not be subsequently adjusted, unless the liability is reassessed for other reasons. Other variable lease payments are primarily comprised of payments affected by common area maintenance and utility charges. |
Warranty costs | ab. Warranty costs: The Company generally provides three months software and a one-year hardware assurance for its products. A provision is recorded for estimated warranty costs at the time revenues are recognized based on the Company's experience. Warranty expenses for the years ended December 31, 2023, 2022 and 2021 were immaterial. |
Recently Adopted Accounting Pronouncements | ac. Recently Adopted Accounting Pronouncements: In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. Specifically, the new guidance requires disclosure, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker, and an amount for other segment items by reportable segment, with a description of its composition. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, and provide new segment disclosure requirements for entities with a single reportable segment. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of the amendments to its consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update require entities to disclose specific categories in the effective tax rate reconciliation and provide additional information for reconciling items where the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income/loss by the applicable statutory income tax rate. In addition, entities are required to disclose the year-to-date amount of income taxes paid (net of refunds received) disaggregated by jurisdictions. This ASU is effective for annual periods beginning after December 15, 2024 with early adoption permitted. The Company is currently evaluating the impact of these amendments on its consolidated financial statements and related disclosures. |
GENERAL (Tables)
GENERAL (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Keepers Child Safety Ltd [Member] | |
Business Acquisition [Line Items] | |
Schedule of the Fair Value of Assets Acquired and Liabilities Assumed | Fair value Technology $ 1,002 Goodwill 150 Net assets acquired $ 1,152 |
SIGNIFICANT ACCOUNTING POLICI_3
SIGNIFICANT ACCOUNTING POLICIES (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Schedule of Allowance of Credit Losses | 2023 2022 2021 Total allowance for credit losses – January 1 2,908 2,398 2,309 Current-period provision for expected credit losses 22,563 823 293 Write-offs (145 ) (64 ) (9 ) Recoveries collected (73 ) (249 ) (195 ) Total allowance for credit losses – December 31 25,253 2,908 2,398 |
Schedule of Estimated Useful Lives at an Annual Rate | % Lab equipment 16 - 25 Computers and peripheral equipment 33 Office furniture 6 SECaaS equipment * 16 Leasehold improvements Over the shorter of the term of the lease or the useful life of the asset * SECaaS equipment – the equipment used for SECaaS revenues |
Schedule of Stock-Based Compensation Expense | Year ended December 31, 2023 2022 2021 Cost of revenues $ 1,219 $ 1,133 $ 581 Research and development 3,010 3,168 2,499 Sales and marketing 2,651 2,943 3,212 General and administrative 1,965 1,921 1,708 Total share-based compensation expense $ 8,845 $ 9,165 $ 8,000 |
Schedule of Accumulated Other Comprehensive Income | Year ended December 31, 2023 Unrealized gain (losses) on marketable securities Unrealized gains (losses) on cash flow hedges Total Balance as of December 31, 2022 $ (40 ) $ (1,214 ) $ (1,254 ) Changes in other comprehensive loss before reclassifications 41 (960 ) (919 ) Amounts reclassified from accumulated other comprehensive loss to: Cost of revenues - 475 475 Research and development - 1,198 1,198 Sales and marketing - 542 542 General and administrative - 441 441 Net current-period other comprehensive loss 41 1,696 1,737 Balance as of December 31, 2023 $ 1 $ 482 $ 483 |
AVAILABLE-FOR-SALE MARKETABLE_2
AVAILABLE-FOR-SALE MARKETABLE SECURITIES (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of summary of Available-for-Sale Marketable Securities | December 31, 2023 December 31, 2022 Amortized cost Gross unrealized gain Gross unrealized Fair value Amortized cost Gross unrealized Gross unrealized Fair value Available-for-sale - matures within one year: Governmental debentures $ 28,495 $ 9 $ - $ 28,504 $ - $ - $ - $ - Corporate debentures 357 - (8 ) 349 4,029 - (37 ) 3,992 28,852 9 (8 ) 28,853 4,029 - (37 ) 3,992 Available-for-sale - matures after one year through three years: Governmental debentures - - - - - - - - Corporate debentures - - - - 304 - (3 ) 301 - - - - 304 - (3 ) 301 $ 28,852 $ 9 $ (8 ) $ 28,853 $ 4,333 $ - $ (40 ) $ 4,293 |
FAIR VALUE MEASUREMENTS (Tables
FAIR VALUE MEASUREMENTS (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Financial Assets Measured at Fair Value on a Recurring Basis | As of December 31, 2023 Fair value measurements using input type Level 1 Level 2 Level 3 Total Assets: Available-for-sale marketable securities $ - $ 28,853 $ - $ 28,853 Foreign currency derivative contracts - 650 - 650 Liabilities: Earn-out liability - - - - Foreign currency derivative contracts - (106 ) - (106 ) Total financial net assets $ - $ 29,397 $ - $ 29,397 As of December 31, 2022 Fair value measurements using input type Level 1 Level 2 Level 3 Total Assets: Available-for-sale marketable securities $ - $ 4,293 $ - $ 4,293 Foreign currency derivative contracts - 23 - 23 Liabilities: Earn-out liability - - (656 ) (656 ) Foreign currency derivative contracts - (901 ) - (901 ) Total financial net assets $ - $ 3,415 $ (656 ) $ 2,759 |
Schedule of Fair Value Measurements Using Significant Unobservable Inputs | Balance at January 1, 2023 $ 656 Earn Out liability – Keepers (656 ) Balance at December 31, 2023 $ - |
DERIVATIVE INSTRUMENTS (Tables)
DERIVATIVE INSTRUMENTS (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Designated as Hedging Instrument [Member] | |
Schedule of the Fair Value of Open Foreign Exchange Contracts | Foreign exchange forward and December 31, options contracts Balance sheet 2023 2022 Fair value of foreign exchange hedge transactions Other receivables and prepaid expenses $ 537 $ 12 Fair value of foreign exchange hedge transactions Other payables and accrued expenses (55 ) (838 ) Total derivatives designated as hedging instruments Other Comprehensive profit (loss) $ 482 $ (1,214 ) |
Not Designated as Hedging Instrument [Member] | |
Schedule of the Fair Value of Open Foreign Exchange Contracts | Foreign exchange forward and December 31, options contracts Balance sheet 2023 2022 Fair value of foreign exchange non-designated hedge transactions Other receivables and prepaid expenses $ 113 $ 11 Fair value of foreign exchange non-designated hedge transactions Other payables and accrued expenses (51 ) (63 ) Total derivatives non-designated as hedging instruments $ 62 $ (52 ) |
OTHER RECEIVABLES AND PREPAID_2
OTHER RECEIVABLES AND PREPAID EXPENSES (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Schedule of other accounts receivable and prepaid expense | December 31, 2023 2022 Prepaid expenses $ 5,890 $ 4,560 Government authorities 988 2,108 Accrued interest 591 1,059 Foreign currency derivative contracts 650 23 Short-term deposits 145 163 Others 173 72 $ 8,437 $ 7,985 |
INVENTORIES (Tables)
INVENTORIES (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory | December 31, 2023 2022 Raw materials $ 1,656 $ 2,003 Finished goods 10,218 11,259 $ 11,874 $ 13,262 |
PROPERTY AND EQUIPMENT, NET (Ta
PROPERTY AND EQUIPMENT, NET (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment | December 31, 2023 2022 Cost: Lab equipment $ 12,750 $ 19,711 Computers and peripheral equipment 11,353 11,856 Office furniture and equipment 1,438 1,568 Leasehold improvements 2,990 3,039 SECaaS equipment 8,036 7,722 36,567 43,896 Accumulated depreciation: Lab equipment 9,835 16,037 Computers and peripheral equipment 9,041 8,239 Office furniture and equipment 535 589 Leasehold improvements 1,692 1,453 SECaaS equipment 4,275 3,342 25,378 29,660 Depreciated cost $ 11,189 $ 14,236 |
INTANGIBLE ASSETS, NET (Tables)
INTANGIBLE ASSETS, NET (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Intangible Assets | December 31, 2023 2022 Gross Carrying Amount: Technology $ 10,113 $ 10,113 Backlog 1,877 1,877 Customer relationships 3,592 3,592 Software license 1,651 1,651 IP R&D 3,659 3,659 $ 20,892 $ 20,892 Accumulated amortization: Technology $ 10,113 $ 9,117 Backlog 1,877 1,877 Customer relationships 3,592 3,592 Software license 1,651 660 IP R&D 2,744 2,135 $ 19,977 $ 17,381 Net Carrying Amount: $ 915 $ 3,511 |
Schedule of Estimated Amortization Expense | Year ending December 31, 2024 $ 610 2025 305 Total $ 915 |
OTHER PAYABLES AND ACCRUED EX_2
OTHER PAYABLES AND ACCRUED EXPENSES (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Payables and Accruals [Abstract] | |
Schedule of Other Payables and Accrued Expenses | December 31, 2023 2022 Accrued expenses $ 5,964 $ 7,056 Deferred revenues from IIA 302 110 Onerous contract liability 551 - Government authorities 2,108 1,955 Foreign currency derivative contracts 106 901 Holdback and contingent earnout 299 1,216 Provision for returns 90 90 Others 108 96 $ 9,528 $ 11,424 |
LEASES (Tables)
LEASES (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule Of Weighted Average Remaining Lease Term And Discount Rate | Year ended December 31, 2023 2022 Weighted average remaining lease term 1.5 years 2.1 years Weighted average discount rate 2.10% 1.49% |
Schedule of Maturities of Operating Lease Liabilities | Year ending December 31, 2024 $ 1,465 2025 673 2026 64 Total lease payments 2,202 Less - imputed interest (47 ) Present value of lease liabilities $ 2,155 |
SHAREHOLDERS' EQUITY (Tables)
SHAREHOLDERS' EQUITY (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Stock Option Activity | Year ended December 31, 2023 2022 2021 Number of shares upon exercise Weighted average exercise price Number of shares upon exercise Weighted average exercise price Number of shares upon exercise Weighted average exercise price Outstanding at beginning of year 487,839 $ 5.96 675,986 $ 7.99 1,134,256 $ 7.68 Forfeited (72,480 ) $ 9.04 (139,494 ) $ 16.08 (30,861 ) $ 16.78 Exercised (1,364 ) $ 0.03 (48,653 ) $ 5.01 (427,409 ) $ 6.54 Outstanding at end of year 413,995 $ 5.44 487,839 $ 5.96 675,986 $ 7.99 Exercisable at end of year 413,995 $ 5.44 487,839 $ 5.96 660,986 $ 8.04 Vested and expected to vest 413,995 $ 5.44 487,839 $ 5.96 675,584 $ 7.99 |
Summary of Restricted Stock Unit Activity | Year ended December 31, 2023 2022 Number of shares upon exercise Weighted average share price Number of shares upon exercise Weighted average share price Outstanding at beginning of year 2,255,620 $ 8.52 1,937,908 $ 12.92 Granted 1,330,500 $ 2.47 1,473,400 $ 5.22 Vested (1,005,532 ) $ 2.19 (829,910 ) $ 15.82 Forfeited (316,889 ) $ 2.38 (325,778 ) $ 5.78 Unvested at end of year 2,263,699 $ 4.95 2,255,620 $ 8.52 |
TAXES ON INCOME (Tables)
TAXES ON INCOME (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Schedule of Pre-tax Income (Loss) | Year ended December 31, 2023 2022 2021 Domestic $ (64,360 ) $ (32,826 ) $ (15,419 ) Foreign 2,640 2,691 2,230 $ (61,720 ) $ (30,135 ) $ (13,189 ) |
Schedule of the Reconciliation of the Theoretical Tax Expenses | Year ended December 31, 2023 2022 2021 Loss before taxes on income $ (61,720 ) $ (30,135 ) $ (13,189 ) Theoretical tax income computed at the Israeli statutory tax rate (23% for the years 2023, 2022 and 2021, respectively) $ (14,196 ) $ (6,931 ) $ (3,034 ) Changes in valuation allowance 13,131 4,116 2,604 Write off of prepaid and withholding taxes 749 1,388 875 Foreign tax rates differences related to subsidiaries 20 46 14 Non-deductible expenses and exempt income (269 ) 512 71 Capital note and inter-company balances release taxes - 544 100 Other expenses and Exchange rate differences ( 37 ) 195 488 Non-deductible share-based compensation expense 1,586 1,925 633 Change in uncertain tax positions 100 100 100 Actual tax expense $ 1,084 $ 1,895 $ 1,851 |
Schedule of Income Tax Expense | Year ended December 31, 2023 2022 2021 Current taxes $ 248 $ 391 $ 334 Deferred taxes expense - - 420 Taxes in respect of previous years (13 ) 16 122 Write off of prepaid and withholding taxes 749 1,388 875 Change in expense associated with tax positions for current year 100 100 100 $ 1,084 $ 1,895 $ 1,851 Year ended December 31, 2023 2022 2021 Domestic $ 822 $ 1,129 $ 973 Foreign 262 766 878 Total $ 1,084 $ 1,895 $ 1,851 Domestic Taxes in respect of previous years $ - $ (20 ) $ 37 Write off of prepaid and withholding taxes 822 1,149 936 Total Domestic $ 822 $ 1,129 $ 973 Foreign Current taxes $ 248 $ 391 $ 334 Deferred taxes expense - - 420 Taxes in respect of previous years (13 ) 36 85 Write off of prepaid and withholding taxes (73 ) 239 (61 ) Change in expense associated with tax positions for current year 100 100 100 Total foreign $ 262 $ 766 $ 878 Total income tax expense (benefit) $ 1,084 $ 1,895 $ 1,851 |
Schedule of Deferred Income Taxes | December 31, 2023 2022 Deferred tax assets: Operating and capital loss carryforwards $ 34,420 $ 25,962 Research and development 8,423 10,260 Employee benefits 1,522 1,286 Intangible assets 353 77 Operating lease liabilities 496 1,178 Stock based compensation expenses 1,733 1,481 Onerous contract 127 - Prepaid and withholding taxes 6,297 5,702 Other temporary differences 543 563 Deferred tax asset before valuation allowance 53,914 46,509 Valuation allowance (49,928 ) (41,917 ) Deferred tax asset net of valuation allowance 3,986 4,592 Deferred tax liability: Intangible assets 3,284 3,354 Operating lease right-of-use assets 702 1,239 Net deferred tax asset $ - $ - |
GEOGRAPHIC INFORMATION (Tables)
GEOGRAPHIC INFORMATION (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Segment Reporting [Abstract] | |
Schedule of Revenues by Geographic Location | Year ended December 31, 2023 2022 2021 Europe $ 39,945 $ 41,773 $ 58,414 Asia and Oceania 20,547 29,888 44,227 Americas 16,542 21,791 19,391 Middle East and Africa (*) 16,116 29,285 23,568 $ 93,150 $ 122,737 $ 145,600 |
Schedule of Major Customers | Year ended December 31, 2023 2022 2021 1 st 15 % - 11 % 15 % - 11 % |
Schedule of Long-Lived Assets by Geographic Location | December 31, 2023 2022 Long-lived assets: Israel $ 13,431 $ 18,472 Other 815 1,151 $ 14,246 $ 19,623 |
FINANCIAL INCOME (EXPENSES), _2
FINANCIAL INCOME (EXPENSES), NET (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Other Income and Expenses [Abstract] | |
Schedule of Financial Income, Net | Year ended December 31, 2023 2022 2021 Financial income: Interest income $ 2,341 $ 1,880 $ 1,045 Amortization/accretion of premium/discount on marketable securities, net 732 - - Exchange rate differences and other 214 292 - Financial expenses: Exchange rate differences and other - - 630 institutions interest Expenses 72 - - Amortization/accretion of premium/discount on marketable securities, net - 38 76 $ 3,215 $ 2,134 $ 339 |
CONVERTIBLE NOTES (Tables)
CONVERTIBLE NOTES (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Scheduled of convertible senior notes | December 31, 2023 2022 Liability: Principal $ 40,000 $ 40,000 Unamortized issuance costs (227 ) (425 ) Net carrying amount $ 39,773 $ 39,575 |
GENERAL (Narrative) (Details)
GENERAL (Narrative) (Details) - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended | 30 Months Ended | ||
Jan. 14, 2018 | Dec. 18, 2022 | Dec. 31, 2023 | Sep. 30, 2020 | Dec. 31, 2021 | |
Business Acquisition [Line Items] | |||||
Fair value of contingent liability | $ 0 | ||||
Impairment on research and development projects | 870 | ||||
Netonomy LTD [Member] | |||||
Business Acquisition [Line Items] | |||||
Acquisition date | Jan. 14, 2018 | Dec. 18, 2022 | |||
Total consideration | $ 3,765 | $ 1,152 | |||
Cash paid to acquire entity | 3,180 | 500 | |||
Acquisition transaction costs | 303 | ||||
Fair value of contingent liability | 282 | $ 652 | $ 0 | $ 834 | |
Holdback amount | $ 1,100 | ||||
Description of claims for indemnification | paid in three installments consisting 40%, 40% and 20% of the Holdback amount following the first, second and 30-months anniversaries of the Closing Date, | The contingent consideration consists of two components: (a) $ 1,000 paid against actual income. (b) All expected revenues exceeding $ 1,000 multiplied by 3.0% limited for the period of 10 years as of Valuation Date | |||
Amount of payments cap | $ 1,100 | ||||
Restricted holdback amount | $ 797 | $ 797 | |||
Keepers Child Safety Ltd [Member] | |||||
Business Acquisition [Line Items] | |||||
Total purchase consideration | $ 1,152 |
GENERAL (Schedule of Estimated
GENERAL (Schedule of Estimated Fair Values of Assets Acquired and Liabilities Assumed) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 18, 2022 |
Business Acquisition [Line Items] | |||
Goodwill | $ 31,833 | $ 31,833 | |
Keepers Child Safety Ltd [Member] | |||
Business Acquisition [Line Items] | |||
Technology | $ 1,002 | ||
Goodwill | 150 | ||
Net assets acquired | $ 1,152 |
SIGNIFICANT ACCOUNTING POLICI_4
SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Exchange rate financial gains and (losses) related revaluation of assets and liabilities | $ 378 | $ 442 | $ (454) | |
Restricted deposits | $ 1,886 | $ 1,050 | ||
Weighted average interest rate of restricted deposits | 4.77% | 5.55% | ||
Short-term deposits, weighted average interest rate | 6.58% | 4.05% | ||
Inventory write-offs | $ 1,558 | $ 905 | 4,593 | |
Cumulative inventory write-off | 8,895 | 8,862 | ||
Goodwill impairment loss | 1,614 | 1,614 | ||
Impairment of Intangible Assets (Excluding Goodwill) | 870 | |||
Reserve for sales returns | 90 | 90 | ||
Severance expense | 6,057 | 3,516 | 2,456 | |
Allowance for credit losses | 25,253 | 2,908 | 2,398 | $ 2,309 |
Amount of past due receivables | 2,000 | |||
Grants participations excluded from research and development costs | 3,129 | 825 | 167 | |
ROU assets | 3,057 | 5,387 | ||
ROU lease liabilites | 2,155 | |||
Remaining performance obligations as of the balance date for long- term | 59,000 | |||
Deferred Costs, Capitalized | 1,572 | 1,863 | ||
Amortization of deferred commission | 1,239 | 1,296 | 1,394 | |
Revenues | 93,150 | 122,737 | 145,600 | |
Fair value of the earn-out | 656 | |||
Current-period provision for expected credit losses | $ 22,563 | $ 823 | $ 293 | |
Restricted Stock Units (RSUs) [Member] | ||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Outstanding options and warrants excluded from the calculation of diluted income per share | 2,665,194 | 2,735,125 | 2,613,894 | |
Minimum [Member] | ||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Annual pre-vesting forfeiture rate | 0% | 0% | 0% | |
Remaining performance obligations as of the balance date for short-term | $ 39,000 | |||
Maximum [Member] | ||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Annual pre-vesting forfeiture rate | 30% | 30% | 30% | |
Remaining performance obligations as of the balance date for long- term | $ 20,000 | |||
Grants from the Israel Innovation Authority [Member] | ||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Grants participations excluded from research and development costs | 552 | $ 539 | $ (42) | |
Grants from the Spain Tax Authorities [Member] | ||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||
Grants participations excluded from research and development costs | $ 2,577 | $ 286 |
SIGNIFICANT ACCOUNTING POLICI_5
SIGNIFICANT ACCOUNTING POLICIES (Schedule of Allowance of Credit Losses) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accounting Policies [Abstract] | |||
Total allowance for credit losses – January 1 | $ 2,908 | $ 2,398 | $ 2,309 |
Current-period provision for expected credit losses | 22,563 | 823 | 293 |
Write-offs | (145) | (64) | (9) |
Recoveries collected | (73) | (249) | (195) |
Total allowance for credit losses - December 31 | $ 25,253 | $ 2,908 | $ 2,398 |
SIGNIFICANT ACCOUNTING POLICI_6
SIGNIFICANT ACCOUNTING POLICIES (Schedule of Estimated Useful Lives at Annual Rates) (Details) | 12 Months Ended | |
Dec. 31, 2023 | ||
Lab equipment [Member] | Minimum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated useful lives, annual rate | 16% | |
Lab equipment [Member] | Maximum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated useful lives, annual rate | 25% | |
Computers and peripheral equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated useful lives, annual rate | 33% | |
Office furniture [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated useful lives, annual rate | 6% | |
SECaaS equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated useful lives, annual rate | 16% | [1] |
Leasehold improvements [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Estimated useful lives | us-gaap:UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember | |
[1]SECaaS equipment – the equipment used for SECaaS revenues |
SIGNIFICANT ACCOUNTING POLICI_7
SIGNIFICANT ACCOUNTING POLICIES (Schedule of Stock-Based Compensation Expense) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total share-based compensation expense | $ 8,845 | $ 9,165 | $ 8,000 |
Cost of revenues [Member] | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total share-based compensation expense | 1,219 | 1,133 | 581 |
Research and Development Expense [Member] | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total share-based compensation expense | 3,010 | 3,168 | 2,499 |
Selling and Marketing Expense [Member] | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total share-based compensation expense | 2,651 | 2,943 | 3,212 |
General and Administrative Expense [Member] | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Total share-based compensation expense | $ 1,965 | $ 1,921 | $ 1,708 |
SIGNIFICANT ACCOUNTING POLICI_8
SIGNIFICANT ACCOUNTING POLICIES (Schedule of Accumulated Other Comprehensive Income) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance | $ (1,254) | ||
Changes in other comprehensive loss before reclassifications | (919) | ||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Net current-period other comprehensive loss | 1,737 | $ (1,525) | $ 125 |
Balance | 483 | (1,254) | |
Unrealized gain (losses) on marketable securities [Member] | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance | (40) | ||
Changes in other comprehensive loss before reclassifications | 41 | ||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Balance | (40) | ||
Unrealized gains (losses) on cash flow hedges [Member] | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Balance | (1,214) | ||
Changes in other comprehensive loss before reclassifications | (960) | ||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Balance | $ (1,214) | ||
Cost of revenues [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Amounts reclassified from accumulated other comprehensive loss | 475 | ||
Cost of revenues [Member] | Unrealized gain (losses) on marketable securities [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Amounts reclassified from accumulated other comprehensive loss | 0 | ||
Cost of revenues [Member] | Unrealized gains (losses) on cash flow hedges [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Amounts reclassified from accumulated other comprehensive loss | 475 | ||
Research and development [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Amounts reclassified from accumulated other comprehensive loss | 1,198 | ||
Research and development [Member] | Unrealized gain (losses) on marketable securities [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Amounts reclassified from accumulated other comprehensive loss | 0 | ||
Research and development [Member] | Unrealized gains (losses) on cash flow hedges [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Amounts reclassified from accumulated other comprehensive loss | 1,198 | ||
Sales and marketing [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Amounts reclassified from accumulated other comprehensive loss | 542 | ||
Sales and marketing [Member] | Unrealized gain (losses) on marketable securities [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Amounts reclassified from accumulated other comprehensive loss | 0 | ||
Sales and marketing [Member] | Unrealized gains (losses) on cash flow hedges [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Amounts reclassified from accumulated other comprehensive loss | 542 | ||
General and administrative [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Amounts reclassified from accumulated other comprehensive loss | 441 | ||
General and administrative [Member] | Unrealized gain (losses) on marketable securities [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Amounts reclassified from accumulated other comprehensive loss | 0 | ||
General and administrative [Member] | Unrealized gains (losses) on cash flow hedges [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Amounts reclassified from accumulated other comprehensive loss | 441 | ||
Operating expenses [Member] | Unrealized gains (losses) on cash flow hedges [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Net current-period other comprehensive loss | 1,696 | ||
Balance | 482 | ||
Financial income, net [Member] | Unrealized gain (losses) on marketable securities [Member] | |||
Amounts reclassified from accumulated other comprehensive loss to: | |||
Net current-period other comprehensive loss | 41 | ||
Balance | $ 1 |
AVAILABLE-FOR-SALE MARKETABLE_3
AVAILABLE-FOR-SALE MARKETABLE SECURITIES (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Debt Securities, Available-for-sale [Line Items] | ||
Amortized cost | $ 28,852 | $ 4,333 |
Gross unrealized gain | 9 | 0 |
Gross unrealized loss | (8) | (40) |
Fair value | 28,853 | 4,293 |
Available-for-sale securities matures within one year [Member] | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized cost | 28,852 | 4,029 |
Gross unrealized gain | 9 | 0 |
Gross unrealized loss | (8) | (37) |
Fair value | 28,853 | 3,992 |
Available-for-sale securities matures within one year [Member] | Governmental debentures [Member] | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized cost | 28,495 | 0 |
Gross unrealized gain | 9 | 0 |
Gross unrealized loss | 0 | 0 |
Fair value | 28,504 | 0 |
Available-for-sale securities matures within one year [Member] | Corporate debentures [Member] | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized cost | 357 | 4,029 |
Gross unrealized gain | 0 | 0 |
Gross unrealized loss | (8) | (37) |
Fair value | 349 | 3,992 |
Available-for-sale securities matures after one year through three years [Member] | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized cost | 0 | 304 |
Gross unrealized gain | 0 | 0 |
Gross unrealized loss | 0 | (3) |
Fair value | 0 | 301 |
Available-for-sale securities matures after one year through three years [Member] | Governmental debentures [Member] | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized cost | 0 | 0 |
Gross unrealized gain | 0 | 0 |
Gross unrealized loss | 0 | 0 |
Fair value | 0 | 0 |
Available-for-sale securities matures after one year through three years [Member] | Corporate debentures [Member] | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized cost | 0 | 304 |
Gross unrealized gain | 0 | 0 |
Gross unrealized loss | 0 | (3) |
Fair value | $ 0 | $ 301 |
FAIR VALUE MEASUREMENTS (Schedu
FAIR VALUE MEASUREMENTS (Schedule of Financial Assets Measured at Fair Value on a Recurring Basis) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Assets: | ||
Available-for-sale marketable securities | $ 28,853 | $ 4,293 |
Foreign currency derivative contracts | 650 | 23 |
Liabilities: | ||
Earn-out liability | 0 | (656) |
Foreign currency derivative contracts | (106) | (901) |
Total financial net assets | 29,397 | 2,759 |
Level 1 [Member] | ||
Assets: | ||
Available-for-sale marketable securities | 0 | 0 |
Foreign currency derivative contracts | 0 | 0 |
Liabilities: | ||
Earn-out liability | 0 | 0 |
Foreign currency derivative contracts | 0 | 0 |
Total financial net assets | 0 | 0 |
Level 2 [Member] | ||
Assets: | ||
Available-for-sale marketable securities | 28,853 | 4,293 |
Foreign currency derivative contracts | 650 | 23 |
Liabilities: | ||
Earn-out liability | 0 | 0 |
Foreign currency derivative contracts | (106) | (901) |
Total financial net assets | 29,397 | 3,415 |
Level 3 [Member] | ||
Assets: | ||
Available-for-sale marketable securities | 0 | 0 |
Foreign currency derivative contracts | 0 | 0 |
Liabilities: | ||
Earn-out liability | 0 | (656) |
Foreign currency derivative contracts | 0 | 0 |
Total financial net assets | $ 0 | $ (656) |
FAIR VALUE MEASUREMENTS (Sche_2
FAIR VALUE MEASUREMENTS (Schedule of fair value measurements using significant unobservable inputs ) (Details) - Level 3 [Member] $ in Thousands | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
Defined Benefit Plan, Plan Assets, Level 3 Reconciliation [Line Items] | |
Balance at | $ 656 |
Earn Out liability – Keepers | (656) |
Balance at | $ 0 |
DERIVATIVE INSTRUMENTS (Narrati
DERIVATIVE INSTRUMENTS (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||
Net losses recognized from currency transactions | $ (42) | $ 1,520 | $ 1,272 |
Unrealized gain (loss) on forward contracts, net | 482 | (1,214) | |
Outstanding hedge transactions | 17,245 | 33,711 | |
Gain or loss on the derivative instruments of other comprehensive loss to cost of revenues | (474) | (503) | |
Gain or loss on the derivative instruments, other comprehensive loss to research and development expenses | (1,196) | (1,955) | |
Gain or loss on the derivative instruments, other comprehensive loss to sales and marketing expenses | (540) | (1,210) | |
Gain or loss on the derivative instruments, other comprehensive loss to general and administrative expenses | (440) | (509) | |
Non-designated hedge transactions | $ 12,459 | $ 11,949 |
DERIVATIVE INSTRUMENTS (Schedul
DERIVATIVE INSTRUMENTS (Schedule of the Fair Value Open Foreign Exchange Contracts) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
Fair value of foreign exchange hedge transactions | $ 537 | $ 12 |
Fair value of foreign exchange hedge transactions | (55) | (838) |
Total derivatives designated as hedging instruments | $ 482 | $ (1,214) |
DERIVATIVE INSTRUMENTS (Sched_2
DERIVATIVE INSTRUMENTS (Schedule of the Fair value of the outstanding non-designated foreign exchange contracts) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Derivative Instruments Schedule Of Fair Value Of Outstanding Non Designated Foreign Exchange Contracts | ||
Fair value of foreign exchange non-designated hedge transactions | $ 113 | $ 11 |
Fair value of foreign exchange non-designated hedge transactions | (51) | (63) |
Total derivatives non-designated as hedging instruments | $ 62 | $ (52) |
OTHER RECEIVABLES AND PREPAID_3
OTHER RECEIVABLES AND PREPAID EXPENSES (Schedule of Other Accounts Receivable and Prepaid Expenses) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | ||
Prepaid expenses | $ 5,890 | $ 4,560 |
Government authorities | 988 | 2,108 |
Accrued interest | 591 | 1,059 |
Foreign currency derivative contracts | 650 | 23 |
Short-term deposits | 145 | 163 |
Others | 173 | 72 |
Other receivables and prepaid expenses | $ 8,437 | $ 7,985 |
INVENTORIES (Details)
INVENTORIES (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 1,656 | $ 2,003 |
Finished goods | 10,218 | 11,259 |
Total inventory | 11,874 | 13,262 |
Cost of goods sold, deferred finished goods inventory | $ 1,788 | $ 1,729 |
PROPERTY AND EQUIPMENT, NET (De
PROPERTY AND EQUIPMENT, NET (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Property, Plant and Equipment [Line Items] | |||
Cost | $ 36,567 | $ 43,896 | |
Accumulated depreciation | 25,378 | 29,660 | |
Deprecated cost | 11,189 | 14,236 | |
Depreciation | 5,536 | 6,406 | $ 4,635 |
Lab equipment [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Cost | 12,750 | 19,711 | |
Accumulated depreciation | 9,835 | 16,037 | |
Computers and peripheral equipment [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Cost | 11,353 | 11,856 | |
Accumulated depreciation | 9,041 | 8,239 | |
Office furniture and equipment [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Cost | 1,438 | 1,568 | |
Accumulated depreciation | 535 | 589 | |
Leasehold improvements [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Cost | 2,990 | 3,039 | |
Accumulated depreciation | 1,692 | 1,453 | |
Security As Service [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Cost | 8,036 | 7,722 | |
Accumulated depreciation | $ 4,275 | $ 3,342 |
INTANGIBLE ASSETS, NET (Narrati
INTANGIBLE ASSETS, NET (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||
Amortization expense | $ 982 | $ 946 | $ 940 |
INTANGIBLE ASSETS, NET (Schedul
INTANGIBLE ASSETS, NET (Schedule of Intangible Assets) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Finite-Lived Intangible Assets [Line Items] | ||
Cost | $ 20,892 | $ 20,892 |
Accumulated amortization | 19,977 | 17,381 |
Net Carrying Amount: | 915 | 3,511 |
Technology [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Cost | 10,113 | 10,113 |
Accumulated amortization | 10,113 | 9,117 |
Backlog [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Cost | 1,877 | 1,877 |
Accumulated amortization | 1,877 | 1,877 |
Customer Relationships [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Cost | 3,592 | 3,592 |
Accumulated amortization | 3,592 | 3,592 |
Software license [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Cost | 1,651 | 1,651 |
Accumulated amortization | 1,651 | 660 |
IP R&D [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Cost | 3,659 | 3,659 |
Accumulated amortization | $ 2,744 | $ 2,135 |
INTANGIBLE ASSETS, NET (Sched_2
INTANGIBLE ASSETS, NET (Schedule of Estimated Amortization Expense) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
2022 | $ 610 | |
2023 | 305 | |
Total | $ 915 | $ 3,511 |
OTHER PAYABLES AND ACCRUED EX_3
OTHER PAYABLES AND ACCRUED EXPENSES (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
OTHER PAYABLES AND ACCRUED EXPENSES [Abstract] | ||
Accrued expenses | $ 5,964 | $ 7,056 |
Deferred revenues from IIA | 302 | 110 |
Onerous contract liability | 551 | 0 |
Government authorities | 2,108 | 1,955 |
Foreign currency derivative contracts | 106 | 901 |
Holdback and contingent earnout | 299 | 1,216 |
Provision for returns | 90 | 90 |
Others | 108 | 96 |
Total other payables and accrued expenses | $ 9,528 | $ 11,424 |
LEASES (Narrative) (Details)
LEASES (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Leases [Abstract] | |||
Rent expense | $ 3,545 | $ 3,784 | $ 3,141 |
Short-term lease expense | 229 | 82 | 92 |
Variable lease costs | 831 | 813 | 732 |
Cash paid for lease liabilities | 4,152 | 2,843 | 3,253 |
Short-term maturities of operating lease liabilities | $ 195 | $ 126 | $ 116 |
LEASES (Schedule of Weighted-Av
LEASES (Schedule of Weighted-Average Remaining Lease Term and Discount Rate) (Details) | Dec. 31, 2023 | Dec. 31, 2022 |
Commitments and Contingencies Disclosure [Abstract] | ||
Weighted-average remaining lease term | 1 year 6 months | 2 years 1 month 6 days |
Weighted-average discount rate | 2.10% | 1.49% |
LEASES (Schedule of Maturities
LEASES (Schedule of Maturities of Operating Lease Liabilities) (Details) $ in Thousands | Dec. 31, 2023 USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
2023 | $ 1,465 |
2024 | 673 |
2025 | 64 |
Total lease payments | 2,202 |
Less - imputed interest | (47) |
Present value of lease liabilities | $ 2,155 |
COMMITMENTS AND CONTINGENT LI_2
COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Details) - USD ($) $ in Thousands | Mar. 06, 2023 | Nov. 02, 2021 | Dec. 31, 2023 |
Commitments and Contingencies Disclosure [Abstract] | |||
Bank guarantees | $ 903 | ||
Guarantees in favor of lease | $ 398 | ||
Damages claimed by Netonomy Ltd | $ 834 | ||
Litigation settlement, paid to two founders | $ 260 |
SHAREHOLDERS' EQUITY (Narrative
SHAREHOLDERS' EQUITY (Narrative) (Details) ₪ / shares in Units, ₪ in Thousands, $ in Thousands | 12 Months Ended | ||||||
Dec. 31, 2023 USD ($) shares | Dec. 31, 2022 USD ($) shares | Dec. 31, 2021 USD ($) | Dec. 31, 2023 ILS (₪) ₪ / shares shares | Dec. 31, 2023 USD ($) shares | Dec. 31, 2022 ₪ / shares | Dec. 31, 2022 USD ($) shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Share capital, amount authorized | ₪ | ₪ 20,000,000 | ||||||
Common Stock, Shares Authorized | shares | 200,000,000 | 200,000,000 | 200,000,000 | ||||
Common Stock, Par or Stated Value Per Share | ₪ / shares | ₪ 0.1 | ₪ 0.1 | |||||
Intrinsic value of options outstanding | $ | $ 3,481 | $ 0 | $ 10 | ||||
Intrinsic value of options exercisable | $ | 3,392 | 1 | 10 | ||||
Intrinsic value of options vested and expected to vest | $ | 3,479 | $ 0 | $ 10 | ||||
Intrinsic value of options exercised | $ | $ 93 | $ 93 | $ 4,113 | ||||
Stock options vested during period | shares | 0 | ||||||
Weighted average remaining contractual life of options outstanding | 6 months 3 days | ||||||
Weighted-average remaining contractual life of exercisable options | 6 months 3 days | ||||||
Stock Compensation Plan [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Unrecognized compensation cost, recognition period | 1 year 7 months 13 days | ||||||
Shares available for future issuance | shares | 252,548 | 252,548 | |||||
Vesting period for plan | 4 years | ||||||
Options, expiration period | 10 years | ||||||
Restricted Stock Units (RSUs) [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Unrecognized compensation cost related to non-vested stock options | $ | $ 8,134,803 | ||||||
Unrecognized compensation cost, recognition period | 1 year 7 months 13 days | ||||||
Granted | shares | 1,330,500 | 1,473,400 | |||||
Restricted Stock Units (RSUs) [Member] | 2016 option plan | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Granted | shares | 1,330,500 | 1,473,400 | |||||
Restricted Stock Units (RSUs) [Member] | 2016 option plan | Maximum [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Vesting period for plan | 4 years | ||||||
Restricted Stock Units (RSUs) [Member] | 2016 option plan | Minimum [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Vesting period for plan | 3 years |
SHAREHOLDERS' EQUITY (Schedule
SHAREHOLDERS' EQUITY (Schedule of Stock Option Activity) (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Number of shares upon exercise | |||
Outstanding at beginning of year | 487,839 | 675,986 | 1,134,256 |
Forfeited | (72,480) | (139,494) | (30,861) |
Exercised | (1,364) | (48,653) | (427,409) |
Outstanding at end of year | 413,995 | 487,839 | 675,986 |
Exercisable at end of year | 413,995 | 487,839 | 660,986 |
Vested and expected to vest | 413,995 | 487,839 | 675,584 |
Weighted average exercise price | |||
Outstanding at beginning of year | $ 5.96 | $ 7.99 | $ 7.68 |
Forfeited | 9.04 | 16.08 | 16.78 |
Exercised | 0.03 | 5.01 | 6.54 |
Outstanding at end of year | 5.44 | 5.96 | 7.99 |
Exercisable at end of year | 5.44 | 5.96 | 8.04 |
Vested and expected to vest | $ 5.44 | $ 5.96 | $ 7.99 |
SHAREHOLDERS' EQUITY (Summary o
SHAREHOLDERS' EQUITY (Summary of Restricted Stock Unit Activity) (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Number of shares upon exercise | ||
Outstanding at beginning of year | 2,255,620 | 1,937,908 |
Granted | 1,330,500 | 1,473,400 |
Vested | (1,005,532) | (829,910) |
Forfeited | (316,889) | (325,778) |
Unvested at end of year | 2,263,699 | 2,255,620 |
Weighted average share price | ||
Outstanding at beginning of year | $ 8.52 | $ 12.92 |
Granted | 2.47 | 5.22 |
Vested | 2.19 | 15.82 |
Forfeited | 2.38 | 5.78 |
Unvested at end of year | $ 4.95 | $ 8.52 |
TAXES ON INCOME (Narrative) (De
TAXES ON INCOME (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Taxes On Income [Line Items] | |||
Revenues | $ 93,150 | $ 122,737 | $ 145,600 |
Israeli Income tax rate | 23% | 23% | 23% |
Net operating loss carry forwards | $ 118,905 | ||
Capital loss carry forwards | 27,191 | ||
Undistributed earnings held by foreign subsidiaries | 5,220 | ||
Foreign tax credits and foreign withholding taxes | 771 | ||
Deferred tax assets valuation allowance | 49,928 | $ 41,917 | |
Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Financing Receivable, Allowance for Credit Loss | 1,043 | $ 943 | |
ISRAEL | |||
Taxes On Income [Line Items] | |||
Write-off prepaid and withholding taxes | 6,297 | ||
United States of America [Member] | Minimum [Member] | |||
Taxes On Income [Line Items] | |||
Net operating loss carry forwards | $ 1,615 | ||
Expiration of operating loss carry forward | Dec. 31, 2027 | ||
United States of America [Member] | Maximum [Member] | |||
Taxes On Income [Line Items] | |||
Net operating loss carry forwards | $ 5,414 | ||
Expiration of operating loss carry forward | Dec. 31, 2037 |
TAXES ON INCOME (Schedule of Pr
TAXES ON INCOME (Schedule of Pre-tax Income (Loss)) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Domestic | $ (64,360) | $ (32,826) | $ (15,419) |
Foreign | 2,640 | 2,691 | 2,230 |
Pre-tax income (loss) | $ (61,720) | $ (30,135) | $ (13,189) |
TAXES ON INCOME (Schedule of th
TAXES ON INCOME (Schedule of the Reconciliation of the Theoretical Tax Expense) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Loss before taxes on income | $ (61,720) | $ (30,135) | $ (13,189) |
Theoretical tax income computed at the Israeli statutory tax rate (23% for the years 2023, 2022 and 2021, respectively) | (14,196) | (6,931) | (3,034) |
Changes in valuation allowance | 13,131 | 4,116 | 2,604 |
Write off of prepaid and withholding taxes | 749 | 1,388 | 875 |
Foreign tax rates differences related to subsidiaries | 20 | 46 | 14 |
Non-deductible expenses and exempt income | (269) | 512 | 71 |
Capital note and inter-company balances release taxes | 0 | 544 | 100 |
Other expenses and Exchange rate differences | (37) | 195 | 488 |
Non-deductible share-based compensation expense | 1,586 | 1,925 | 633 |
Change in uncertain tax positions | 100 | 100 | 100 |
Actual tax expense | $ 1,084 | $ 1,895 | $ 1,851 |
TAXES ON INCOME (Schedule of In
TAXES ON INCOME (Schedule of Income Tax Expense (Benefit)) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Current taxes | $ 248 | $ 391 | $ 334 |
Deferred taxes expense | 0 | 0 | 420 |
Taxes in respect of previous years | (13) | 16 | 122 |
Write off of prepaid and withholding taxes | 749 | 1,388 | 875 |
Change in uncertain tax positions | 100 | 100 | 100 |
Income Tax Expense (Benefit) | $ 1,084 | $ 1,895 | $ 1,851 |
TAXES ON INCOME (Schedule of _2
TAXES ON INCOME (Schedule of Income Tax Expense (Benefit) by jurisdiction) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Domestic | $ 822 | $ 1,129 | $ 973 |
Foreign | 262 | 766 | 878 |
Total | 1,084 | 1,895 | 1,851 |
Domestic | |||
Taxes in respect of previous years | 0 | (20) | 37 |
Write off of prepaid and withholding taxes | 822 | 1,149 | 936 |
Total Domestic | 822 | 1,129 | 973 |
Foreign | |||
Current taxes | 248 | 391 | 334 |
Deferred taxes expense | 0 | 0 | 420 |
Taxes in respect of previous years | (13) | 36 | 85 |
Write off of prepaid and withholding taxes | (73) | 239 | (61) |
Change in expense associated with tax positions for current year | 100 | 100 | 100 |
Total foreign | 262 | 766 | 878 |
Total income tax expense (benefit) | $ 1,084 | $ 1,895 | $ 1,851 |
TAXES ON INCOME (Schedule of De
TAXES ON INCOME (Schedule of Deferred Income Taxes) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Deferred tax assets: | ||
Operating and capital loss carryforwards | $ 34,420 | $ 25,962 |
Research and development | 8,423 | 10,260 |
Employee benefits | 1,522 | 1,286 |
Intangible assets | 353 | 77 |
Operating lease liabilities | 496 | 1,178 |
Stock based compensation expenses | 1,733 | 1,481 |
Onerous contract | 127 | 0 |
Prepaid and withholding taxes | 6,297 | 5,702 |
Other temporary differences | 543 | 563 |
Deferred tax asset before valuation allowance | 53,914 | 46,509 |
Valuation allowance | (49,928) | (41,917) |
Deferred tax asset net of valuation allowance | 3,986 | 4,592 |
Deferred tax liability: | ||
Intangible assets | 3,284 | 3,354 |
Operating lease right-of-use assets | 702 | 1,239 |
Net deferred tax asset | $ 0 | $ 0 |
GEOGRAPHIC INFORMATION (Schedul
GEOGRAPHIC INFORMATION (Schedule of Revenue by Geographic Location) (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | ||
Segment Reporting, Revenue Reconciling Item [Line Items] | ||||
Revenues | $ 93,150 | $ 122,737 | $ 145,600 | |
Europe [Member] | ||||
Segment Reporting, Revenue Reconciling Item [Line Items] | ||||
Revenues | 39,945 | 41,773 | 58,414 | |
Asia And Oceania [Member] | ||||
Segment Reporting, Revenue Reconciling Item [Line Items] | ||||
Revenues | 20,547 | 29,888 | 44,227 | |
Americas [Member] | ||||
Segment Reporting, Revenue Reconciling Item [Line Items] | ||||
Revenues | 16,542 | 21,791 | 19,391 | |
Middle East And Africa [Member] | ||||
Segment Reporting, Revenue Reconciling Item [Line Items] | ||||
Revenues | [1] | 16,116 | 29,285 | 23,568 |
ISRAEL [Member] | ||||
Segment Reporting, Revenue Reconciling Item [Line Items] | ||||
Revenues | $ 1 | $ 1 | $ 1 | |
[1]As of December 31, 2023, 2022 and 2021, 1% from total revenues represent revenues in Israel |
GEOGRAPHIC INFORMATION (Sched_2
GEOGRAPHIC INFORMATION (Schedule of Major Customers) (Details) - Sales [Member] - Customer Concentration Risk [Member] | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenue, Major Customer [Line Items] | |||
Concentration risk, threshold percentage | 15% | 0% | 11% |
Network intelligence solutions [Member] | |||
Revenue, Major Customer [Line Items] | |||
Concentration risk percentage | 77% | 77% | 72% |
Security Solutions [Member] | |||
Revenue, Major Customer [Line Items] | |||
Concentration risk percentage | 23% | 23% | 28% |
Customer A [Member] | |||
Revenue, Major Customer [Line Items] | |||
Concentration risk percentage | 15% | 0% | 11% |
GEOGRAPHIC INFORMATION (Sched_3
GEOGRAPHIC INFORMATION (Schedule of Long-Lived Assets) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Long-lived assets | $ 14,246 | $ 19,623 |
ISRAEL | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Long-lived assets | 13,431 | 18,472 |
Other [Member] | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Long-lived assets | $ 815 | $ 1,151 |
FINANCIAL INCOME (EXPENSES), _3
FINANCIAL INCOME (EXPENSES), NET (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Financial income: | |||
Interest income | $ 2,341 | $ 1,880 | $ 1,045 |
Amortization/accretion of premium/discount on marketable securities, net | 732 | 0 | 0 |
Realized Gain (Loss), Foreign Currency Transaction, before Tax | 214 | 292 | 0 |
Financial expenses: | |||
Exchange rate differences and other | 0 | 0 | 630 |
institutions interest Expenses | 72 | 0 | 0 |
Amortization/accretion of premium/discount on marketable securities, net | 0 | 38 | 76 |
Financial and other expenses, total | $ 3,215 | $ 2,134 | $ 339 |
RELATED PARTIES BALANCES AND _2
RELATED PARTIES BALANCES AND TRANSACTIONS (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Feb. 14, 2022 | |
Related Party Transaction [Line Items] | |||
Other payables balance due to related party | $ 24 | $ 93 | |
Convertible Notes | |||
Related Party Transaction [Line Items] | |||
Principal amount | 40,000 | 40,000 | |
Amortization of debt issuance costs | 198 | 171 | |
Galil Software [Member] | |||
Related Party Transaction [Line Items] | |||
Payments to related party for services | 325 | 993 | |
Lynrock Lake Master Fund LP [Member] | Convertible Notes | |||
Related Party Transaction [Line Items] | |||
Principal amount | 40,000 | $ 40,000 | |
Amortization of debt issuance costs | 198 | 171 | |
Convertible debt balances due | $ 39,773 | $ 39,575 |
CONVERTIBLE NOTES (Narrative) (
CONVERTIBLE NOTES (Narrative) (Details) - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended | |
Feb. 14, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Debt Instrument [Line Items] | |||
Change of control conversion description | conversion or redemption in connection with a change in control, the company will also be required to pay the holder an amount in cash equal to 6% per annum on the then-outstanding principal amount of the note from the date of such conversion or redemption trough the maturity date | ||
Convertible Notes | |||
Debt Instrument [Line Items] | |||
Principal amount | $ 40,000 | $ 40,000 | |
Term of debt issuance costs amortization | 3 years | ||
Total Issuance Costs | $ 596 | ||
Debt interest rate | 0.14% | ||
Amortization of debt issuance costs | $ 198 | 171 | |
Convertible Notes | Lynrock Lake Master Fund LP [Member] | |||
Debt Instrument [Line Items] | |||
Principal amount | $ 40,000 | 40,000 | |
Maturity date | Feb. 14, 2025 | ||
conversion price decreases by | up to two $1 increments if the company elects to extend the maturity of the Note by up to two successive years | ||
Conversion rate description | The Note is convertible into the company's ordinary shares at an initial conversion rate of 97.0874 ordinary shares per $1,000 of the principal amount being converted (based on an initial conversion price equal to $10.30 per ordinary share). | ||
Amortization of debt issuance costs | $ 198 | $ 171 |
CONVERTIBLE NOTES (Details)
CONVERTIBLE NOTES (Details) - Convertible Senior Notes - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net [Abstract] | ||
Principle | $ 40,000 | $ 40,000 |
Unamortized issuance costs | (227) | (425) |
Net carrying amount | $ 39,773 | $ 39,575 |